Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Mary M. Horowitz MD, MS

Mary M. Horowitz MD, MS

Center Director, Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology
Program: Hematology

Member of the Cancer Center


Leadership Positions

  • Chief Scientific Director, Center for International Blood and Marrow Transplant Research
  • Associate Director for Cancer Genomics
  • MCW Program / Core Facilities

  • Center for International Blood and Marrow Transplant Research
  • Publications

  • Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. (Eapen M, Wang T, Veys PA, Boelens JJ, Martin AS, Spellman S, Bonfim CS, Brady C, Cant AJ, Dalle JH, Davies SM, Freeman J, Hsu KC, Fleischhauer K, Kenzey C, Kurtzberg J, Michel G, Orchard PJ, Paviglianiti A, Rocha V, Veneris MR, Volt F, Wynn R, Lee SJ, Horowitz MM, Gluckman E, Ruggeri A) Lancet Haematol 2017 Jun 13 PMID: 28623181 06/18/2017
  • Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. (Kanate AS, Hari PN, Pasquini MC, Visotcky A, Ahn KW, Boyd J, Guru Murthy GS, Rizzo JD, Saber W, Drobyski W, Michaelis L, Atallah E, Carlson KS, D'Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, Horowitz MM, Hamadani M) Biol Blood Marrow Transplant 2017 Apr 12 PMID: 28412518 04/17/2017
  • Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes. (Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick ED, Fernandez HF, Alyea EP, Hamadani M, Bashey A, Giralt S, Geller NL, Leifer E, Le-Rademacher J, Mendizabal AM, Horowitz MM, Deeg HJ, Horwitz ME) J Clin Oncol 2017 Apr 10;35(11):1154-1161 PMID: 28380315 PMCID: PMC5455603 04/06/2017
  • Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission. (Weisdorf DJ, Millard HR, Horowitz MM, Hyare PS, Champlin R, Ho V, Mielcarek M, Rezvani A, Stockerl-Goldstein K, Khoury HJ, De Lima M, Saber W, Sandmaier B, Zhang MJ, Eapen M) Cancer 2017 Jun 01;123(11):2025-2034 PMID: 28117884 PMCID: PMC5445001 01/25/2017
  • Transplantation for myelodysplastic syndromes: who, when, and which conditioning regimens. (Saber W, Horowitz MM) Hematology Am Soc Hematol Educ Program 2016 Dec 02;2016(1):478-484 PMID: 27913519 12/04/2016
  • Health-Related Quality of Life among Pediatric Hematopoietic Stem Cell Donors. (Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, van Walraven SM, Wiener L, Packman W, Varni JW, Pulsipher MA) J Pediatr 2016 Nov;178:164-170.e1 PMID: 27522440 PMCID: PMC5085860 10/30/2016
  • Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study. (Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, Riches M, Hayes-Lattin B, Linenberger M, Bolwell B, Rowley SD, Litzow MR, Pulsipher MA) Biol Blood Marrow Transplant 2017 Jan;23(1):165-171 PMID: 27751935 PMCID: PMC5182103 10/19/2016
  • A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. (Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N) Blood 2016 Nov 24;128(21):2561-2567 PMID: 27625358 PMCID: PMC5123194 09/15/2016
  • Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial. (Knight JM, Syrjala KL, Majhail NS, Martens M, Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim HS, Wingard JR, Horowitz MM, Abidi MH, Fei M, Rawls L, Rizzo JD) Biol Blood Marrow Transplant 2016 Dec;22(12):2256-2263 PMID: 27565521 PMCID: PMC5116244 08/28/2016
  • Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial. (Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE, Confer D, Horowitz MM, Anasetti C) JAMA Oncol 2016 Dec 01;2(12):1583-1589 PMID: 27532508 PMCID: PMC5145732 08/18/2016
  • Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis. (O'Donnell PV, Eapen M, Horowitz MM, Logan BR, DiGilio A, Brunstein C, Fuchs EJ, Flowers ME, Salit R, Raj K, Pagliuca A, Bradstock K, Granata A, Castagna L, Furst S, Blaise D) Bone Marrow Transplant 2016 Dec;51(12):1599-1601 PMID: 27526284 PMCID: PMC5143194 08/16/2016
  • Practice Patterns and Preferences Among Hematopoietic Cell Transplantation Clinicians. (Wood WA, McGinn MK, Wilson D, Deal AM, Khera N, Shea TC, Devine SM, Appelbaum FR, Horowitz MM, Lee SJ) Biol Blood Marrow Transplant 2016 Nov;22(11):2092-2099 PMID: 27481447 PMCID: PMC5067220 08/03/2016
  • Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft. (Epperla N, Pasquini M, Pierce K, Drobyski WR, Rizzo JD, Horowitz MM, Saber W, Zellner K, Ramirez S, Bartz K, Raj RV, Hari PN, Hamadani M) Bone Marrow Transplant 2017 Jan;52(1):147-150 PMID: 27479688 08/02/2016
  • The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation. (Steering Committee Of The Blood And Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2016 Oct;22(10):1747-57 PMID: 27418009 PMCID: PMC5027144 07/16/2016
  • Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation. (Ballen K, Woo Ahn K, Chen M, Abdel-Azim H, Ahmed I, Aljurf M, Antin J, Bhatt AS, Boeckh M, Chen G, Dandoy C, George B, Laughlin MJ, Lazarus HM, MacMillan ML, Margolis DA, Marks DI, Norkin M, Rosenthal J, Saad A, Savani B, Schouten HC, Storek J, Szabolcs P, Ustun C, Verneris MR, Waller EK, Weisdorf DJ, Williams KM, Wingard JR, Wirk B, Wolfs T, Young JA, Auletta J, Komanduri KV, Lindemans C, Riches ML) Biol Blood Marrow Transplant 2016 Sep;22(9):1636-45 PMID: 27343716 PMCID: PMC5008458 06/28/2016
  • Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. (Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, Devine S, Baiocchi R, Lozanski G, Kaplan L, Noy A, Popat U, Hsu J, Morris LE Jr, Thompson J, Horowitz MM, Mendizabal A, Levine A, Krishnan A, Forman SJ, Navarro WH, Ambinder R) Blood 2016 Aug 25;128(8):1050-8 PMID: 27297790 PMCID: PMC5000843 06/15/2016
  • Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research. (Lazaryan A, Wang T, Spellman SR, Wang HL, Pidala J, Nishihori T, Askar M, Olsson R, Oudshoorn M, Abdel-Azim H, Yong A, Gandhi M, Dandoy C, Savani B, Hale G, Page K, Bitan M, Reshef R, Drobyski W, Marsh SG, Schultz K, Müller CR, Fernandez-Viña MA, Verneris MR, Horowitz MM, Arora M, Weisdorf DJ, Lee SJ) Haematologica 2016 Oct;101(10):1267-1274 PMID: 27247320 PMCID: PMC5046657 06/02/2016
  • Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN. (Shaw BE, Lee SJ, Horowitz MM, Wood WA, Rizzo JD, Flynn KE) Bone Marrow Transplant 2016 Sep;51(9):1173-9 PMID: 27159181 05/10/2016
  • Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation. (Arora M, Lee SJ, Spellman SR, Weisdorf DJ, Guan W, Haagenson M, Wang T, Horowitz MH, Verneris MR, Fleischhauer K, Hsu K, Thyagarajan B) Biol Blood Marrow Transplant 2016 Aug;22(8):1531-2 PMID: 27155583 PMCID: PMC5364725 05/08/2016
  • Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network. (Laport GG, Wu J, Logan B, Bachanova V, Hosing C, Fenske T, Longo W, Devine SM, Nademanee A, Gersten I, Horowitz M, Lazarus HM, Riches ML, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2016 Aug;22(8):1440-8 PMID: 27118571 PMCID: PMC4949103 04/28/2016
  • Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research. (Strouse C, Richardson P, Prentice G, Korman S, Hume R, Nejadnik B, Horowitz MM, Saber W) Biol Blood Marrow Transplant 2016 Jul;22(7):1306-12 PMID: 27108694 PMCID: PMC4914048 04/26/2016
  • The Impact of Palifermin Use on Hematopoietic Cell Transplant Outcomes in Children. (Saber W, Zhang MJ, Steinert P, Chen M, Horowitz MM) Biol Blood Marrow Transplant 2016 Aug;22(8):1460-6 PMID: 27090960 PMCID: PMC4949099 04/20/2016
  • Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. (Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y, Bouzas LF, Confer D, Greinix H, Horowitz M, Iida M, Lipton J, Mohty M, Novitzky N, Nunez J, Passweg J, Pasquini MC, Kodera Y, Apperley J, Seber A, Gratwohl A) Bone Marrow Transplant 2016 Jun;51(6):778-85 PMID: 26901703 PMCID: PMC4889523 02/24/2016
  • Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014. (Al Malki MM, Horowitz M, Handgretinger R, Leung W, Roy DC, Huang XJ, Fuchs E, Locatelli F, Blaise D, Mineishi S, Martelli M, Miller J, June C, Ai HS, Luznik L, Mavilio D, Lugli E, van den Brink MR, Champlin RE, Ciurea SO) Biol Blood Marrow Transplant 2016 Apr;22(4):594-604 PMID: 26806585 01/26/2016
  • Global Use of Peripheral Blood vs Bone Marrow as Source of Stem Cells for Allogeneic Transplantation in Patients With Bone Marrow Failure. (Yoshimi A, Baldomero H, Horowitz M, Szer J, Niederwieser D, Gratwohl A, Kodera Y, Worldwide Network of Blood and Marrow Transplantation (WBMT)) JAMA 2016 Jan 12;315(2):198-200 PMID: 26757470 01/13/2016
  • One million haemopoietic stem-cell transplants: a retrospective observational study. (Gratwohl A, Pasquini MC, Aljurf M, Atsuta Y, Baldomero H, Foeken L, Gratwohl M, Bouzas LF, Confer D, Frauendorfer K, Gluckman E, Greinix H, Horowitz M, Iida M, Lipton J, Madrigal A, Mohty M, Noel L, Novitzky N, Nunez J, Oudshoorn M, Passweg J, van Rood J, Szer J, Blume K, Appelbaum FR, Kodera Y, Niederwieser D, Worldwide Network for Blood and Marrow Transplantation (WBMT)) Lancet Haematol 2015 Mar;2(3):e91-100 PMID: 26687803 12/22/2015
  • Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study. (Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin JH, Adams R, Arai S, Eames G, Horwitz ME, McCarty J, Nakamura R, Pulsipher MA, Rowley S, Leifer E, Carter SL, DiFronzo NL, Horowitz MM, Confer D, Deeg HJ, Eapen M) Lancet Haematol 2015 Sep;2(9):e367-75 PMID: 26685770 PMCID: PMC4861234 12/22/2015
  • The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. (Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Viña M, Hartzman RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, Mueller CR, Perales MA, Setterholm M, Woolfrey AE, Yu N, Eapen M) Blood 2016 Jan 14;127(2):260-7 PMID: 26527675 PMCID: PMC4713163 11/04/2015
  • Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502. (Devine SM, Owzar K, Blum W, Mulkey F, Stone RM, Hsu JW, Champlin RE, Chen YB, Vij R, Slack J, Soiffer RJ, Larson RA, Shea TC, Hars V, Sibley AB, Giralt S, Carter S, Horowitz MM, Linker C, Alyea EP) J Clin Oncol 2015 Dec 10;33(35):4167-75 PMID: 26527780 PMCID: PMC4658453 11/04/2015
  • Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). (Wood WA, Le-Rademacher J, Syrjala KL, Jim H, Jacobsen PB, Knight JM, Abidi MH, Wingard JR, Majhail NS, Geller NL, Rizzo JD, Fei M, Wu J, Horowitz MM, Lee SJ) Cancer 2016 Jan 01;122(1):91-8 PMID: 26439325 PMCID: PMC4707096 10/07/2015
  • Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. (Young JA, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, Pergam SA, Marty FM, Strasfeld LM, Brown JW, Langston AA, Schuster MG, Kaul DR, Martin SI, Anasetti C, Blood and Marrow Transplant Clinical Trials Network Trial 0201) Biol Blood Marrow Transplant 2016 Feb;22(2):359-70 PMID: 26409243 PMCID: PMC4716871 09/27/2015
  • High HLA-DP Expression and Graft-versus-Host Disease. (Petersdorf EW, Malkki M, O'hUigin C, Carrington M, Gooley T, Haagenson MD, Horowitz MM, Spellman SR, Wang T, Stevenson P) N Engl J Med 2015 Aug 13;373(7):599-609 PMID: 26267621 PMCID: PMC4560117 08/13/2015
  • Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. (Ciurea SO, Zhang MJ, Bacigalupo AA, Bashey A, Appelbaum FR, Aljitawi OS, Armand P, Antin JH, Chen J, Devine SM, Fowler DH, Luznik L, Nakamura R, O'Donnell PV, Perales MA, Pingali SR, Porter DL, Riches MR, Ringdén OT, Rocha V, Vij R, Weisdorf DJ, Champlin RE, Horowitz MM, Fuchs EJ, Eapen M) Blood 2015 Aug 20;126(8):1033-40 PMID: 26130705 PMCID: PMC4543223 07/02/2015
  • Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial. (Khera N, Majhail NS, Brazauskas R, Wang Z, He N, Aljurf MD, Akpek G, Atsuta Y, Beattie S, Bredeson CN, Burns LJ, Dalal JD, Freytes CO, Gupta V, Inamoto Y, Lazarus HM, LeMaistre CF, Steinberg A, Szwajcer D, Wingard JR, Wirk B, Wood WA, Joffe S, Hahn TE, Loberiza FR, Anasetti C, Horowitz MM, Lee SJ) Biol Blood Marrow Transplant 2015 Oct;21(10):1815-22 PMID: 26071866 PMCID: PMC4568172 06/15/2015
  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report. (Martin PJ, Lee SJ, Przepiorka D, Horowitz MM, Koreth J, Vogelsang GB, Walker I, Carpenter PA, Griffith LM, Akpek G, Mohty M, Wolff D, Pavletic SZ, Cutler CS) Biol Blood Marrow Transplant 2015 Aug;21(8):1343-59 PMID: 25985921 PMCID: PMC4506719 05/20/2015
  • Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. (Graff TM, Singavi AK, Schmidt W, Eastwood D, Drobyski WR, Horowitz M, Palmer J, Pasquini M, Rizzo DJ, Saber W, Hari P, Fenske TS) Bone Marrow Transplant 2015 Jul;50(7):947-53 PMID: 25867651 PMCID: PMC4490016 04/14/2015
  • Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. (Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC) Biol Blood Marrow Transplant 2015 Aug;21(8):1479-87 PMID: 25862591 PMCID: PMC4512746 04/12/2015
  • Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation. (Eapen M, Logan BR, Horowitz MM, Zhong X, Perales MA, Lee SJ, Rocha V, Soiffer RJ, Champlin RE) J Clin Oncol 2015 Feb 01;33(4):364-9 PMID: 25534391 PMCID: PMC4302216 12/24/2014
  • Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation. (Copelan EA, Avalos BR, Ahn KW, Zhu X, Gale RP, Grunwald MR, Hamadani M, Hamilton BK, Hale GA, Marks DI, Waller EK, Savani BN, Costa LJ, Ramanathan M, Cahn JY, Khoury HJ, Weisdorf DJ, Inamoto Y, Kamble RT, Schouten HC, Wirk B, Litzow MR, Aljurf MD, van Besien KW, Ustun C, Bolwell BJ, Bredeson CN, Fasan O, Ghosh N, Horowitz MM, Arora M, Szer J, Loren AW, Alyea EP, Cortes J, Maziarz RT, Kalaycio ME, Saber W) Biol Blood Marrow Transplant 2015 Mar;21(3):552-8 PMID: 25528388 PMCID: PMC4329042 12/22/2014
  • Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort. (Arora M, Hemmer MT, Ahn KW, Klein JP, Cutler CS, Urbano-Ispizua A, Couriel DR, Alousi AM, Gale RP, Inamoto Y, Weisdorf DJ, Li P, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola LM, Jacobsohn DA, Jagasia M, Klumpp TR, Petersdorf EW, Santarone S, Schouten HC, Wingard JR, Spellman SR, Pavletic SZ, Lee SJ, Horowitz MM, Flowers ME) Biol Blood Marrow Transplant 2015 Apr;21(4):640-5 PMID: 25528390 PMCID: PMC4359642 12/22/2014
  • Blood and marrow transplant clinical trials network state of the Science Symposium 2014. (Appelbaum FR, Anasetti C, Antin JH, Atkins H, Davies S, Devine S, Giralt S, Heslop H, Laport G, Lee SJ, Logan B, Pasquini M, Pulsipher M, Stadtmauer E, Wingard JR, Horowitz MM) Biol Blood Marrow Transplant 2015 Feb;21(2):202-24 PMID: 25445636 PMCID: PMC4426907 12/03/2014
  • Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. (Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy PL, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ, Graft-vs-Host Disease Working Committee of the CIBMTR) Biol Blood Marrow Transplant 2015 Feb;21(2):266-74 PMID: 25445023 PMCID: PMC4326247 12/03/2014
  • One-unit versus two-unit cord-blood transplantation for hematologic cancers. (Wagner JE Jr, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J, Blood and Marrow Transplant Clinical Trials Network) N Engl J Med 2014 Oct 30;371(18):1685-94 PMID: 25354103 PMCID: PMC4257059 10/30/2014
  • Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia. (Boyiadzis M, Arora M, Klein JP, Hassebroek A, Hemmer M, Urbano-Ispizua A, Antin JH, Bolwell BJ, Cahn JY, Cairo MS, Cutler CS, Flowers ME, Gale RP, Herzig R, Isola LM, Jacobsohn DA, Jagasia MH, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Spellman SR, Schouten HC, Verdonck LF, Wingard JR, Weisdorf DJ, Horowitz MM, Pavletic SZ) Clin Cancer Res 2015 May 01;21(9):2020-8 PMID: 25348512 PMCID: PMC4411210 10/29/2014
  • HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation. (Petersdorf EW, Gooley TA, Malkki M, Bacigalupo AP, Cesbron A, Du Toit E, Ehninger G, Egeland T, Fischer GF, Gervais T, Haagenson MD, Horowitz MM, Hsu K, Jindra P, Madrigal A, Oudshoorn M, Ringdén O, Schroeder ML, Spellman SR, Tiercy JM, Velardi A, Witt CS, O'Huigin C, Apps R, Carrington M, International Histocompatibility Working Group in Hematopoietic Cell Transplantation) Blood 2014 Dec 18;124(26):3996-4003 PMID: 25323824 PMCID: PMC4271183 10/18/2014
  • Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). (Howard CA, Fernandez-Vina MA, Appelbaum FR, Confer DL, Devine SM, Horowitz MM, Mendizabal A, Laport GG, Pasquini MC, Spellman SR) Biol Blood Marrow Transplant 2015 Jan;21(1):4-7 PMID: 25278457 PMCID: PMC4272893 10/04/2014
  • Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802. (Bolaños-Meade J, Logan BR, Alousi AM, Antin JH, Barowski K, Carter SL, Goldstein SC, Hexner EO, Horowitz MM, Lee SJ, Levine JE, MacMillan ML, Martin PJ, Mendizabal AM, Nakamura R, Pasquini MC, Weisdorf DJ, Westervelt P, Ho VT) Blood 2014 Nov 20;124(22):3221-7; quiz 3335 PMID: 25170121 PMCID: PMC4239331 08/30/2014
  • Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. (Pidala J, Lee SJ, Ahn KW, Spellman S, Wang HL, Aljurf M, Askar M, Dehn J, Fernandez Viña M, Gratwohl A, Gupta V, Hanna R, Horowitz MM, Hurley CK, Inamoto Y, Kassim AA, Nishihori T, Mueller C, Oudshoorn M, Petersdorf EW, Prasad V, Robinson J, Saber W, Schultz KR, Shaw B, Storek J, Wood WA, Woolfrey AE, Anasetti C) Blood 2014 Oct 16;124(16):2596-606 PMID: 25161269 PMCID: PMC4199961 08/28/2014
  • HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. (Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, Hartzman R, Rizzo JD, Horowitz M, Confer D, Maiers M) N Engl J Med 2014 Jul 24;371(4):339-48 PMID: 25054717 07/24/2014
  • Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. (Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D, Hogan WJ, Pasquini M, MacMillan ML, Hsu JW, Waller EK, Grupp S, McCarthy P, Wu J, Hu ZH, Carter SL, Horowitz MM, Antin JH) Blood 2014 Aug 21;124(8):1372-7 PMID: 24982504 PMCID: PMC4141519 07/02/2014
  • Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods. (Saber W, Le Rademacher J, Sekeres M, Logan B, Lewis M, Mendizabal A, Leifer E, Appelbaum FR, Horowitz MM, Nakamura R, Cutler CS) Biol Blood Marrow Transplant 2014 Oct;20(10):1566-72 PMID: 24972249 PMCID: PMC4169902 06/28/2014
  • Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. (Jacobsen PB, Le-Rademacher J, Jim H, Syrjala K, Wingard JR, Logan B, Wu J, Majhail NS, Wood W, Rizzo JD, Geller NL, Kitko C, Faber E, Abidi MH, Slater S, Horowitz MM, Lee SJ) Biol Blood Marrow Transplant 2014 Oct;20(10):1530-6 PMID: 24910380 PMCID: PMC4163109 06/10/2014
  • Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts. (Aljurf M, Rizzo JD, Mohty M, Hussain F, Madrigal A, Pasquini MC, Passweg J, Chaudhri N, Ghavamzadeh A, Solh HE, Atsuta Y, Szer J, Kodera Y, Niederweiser D, Gratwohl A, Horowitz MM) Bone Marrow Transplant 2014 Aug;49(8):1016-21 PMID: 24777183 04/30/2014
  • Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. (Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W) Blood 2014 Jun 05;123(23):3664-71 PMID: 24744269 PMCID: PMC4047501 04/20/2014
  • Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol. (Yanik GA, Horowitz MM, Weisdorf DJ, Logan BR, Ho VT, Soiffer RJ, Carter SL, Wu J, Wingard JR, Difronzo NL, Ferrara JL, Giralt S, Madtes DK, Drexler R, White ES, Cooke KR) Biol Blood Marrow Transplant 2014 Jun;20(6):858-64 PMID: 24607553 PMCID: PMC4128626 03/13/2014
  • Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. (Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M, Center for International Blood and Marrow Transplant Research (CIBMTR), and Donor/Source and GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)) Biol Blood Marrow Transplant 2014 May;20(5):662-7 PMID: 24525277 PMCID: PMC4071962 02/15/2014
  • Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. (Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, Arcese W, Barker JN, Baxter-Lowe LA, Brown M, Fernandez-Vina MA, Freeman J, He W, Iori AP, Horowitz MM, Locatelli F, Marino S, Maiers M, Michel G, Sanz GF, Gluckman E, Rocha V, Center for International Blood and Marrow Transplant Research, Netcord, Eurocord, and the European Group for Blood and Marrow Transplantation) Blood 2014 Jan 02;123(1):133-40 PMID: 24141369 PMCID: PMC3879902 10/22/2013
  • Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. (Copelan EA, Hamilton BK, Avalos B, Ahn KW, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn JY, Costa LJ, de Lima M, Gale RP, Hale GA, Halter J, Hamadani M, Inamoto Y, Kamble RT, Litzow MR, Loren AW, Marks DI, Olavarria E, Roy V, Sabloff M, Savani BN, Seftel M, Schouten HC, Ustun C, Waller EK, Weisdorf DJ, Wirk B, Horowitz MM, Arora M, Szer J, Cortes J, Kalaycio ME, Maziarz RT, Saber W) Blood 2013 Dec 05;122(24):3863-70 PMID: 24065243 PMCID: PMC3854108 09/26/2013
  • Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. (Mauskopf J, Chirila C, Graham J, Gersten ID, Leather H, Maziarz RT, Baden LR, Bolaños-Meade J, Brown JM, Walsh TJ, Horowitz MH, Kurtzberg J, Marr KA, Wingard JR) Am J Health Syst Pharm 2013 Sep 01;70(17):1518-27 PMID: 23943184 PMCID: PMC4019750 08/15/2013
  • Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). (Saber W, Cutler CS, Nakamura R, Zhang MJ, Atallah E, Rizzo JD, Maziarz RT, Cortes J, Kalaycio ME, Horowitz MM) Blood 2013 Sep 12;122(11):1974-82 PMID: 23847196 PMCID: PMC3772501 07/13/2013
  • Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma. (Cornell RF, Hari P, Zhang MJ, Zhong X, Thompson J, Fenske TS, Horowitz MM, Komorowski R, Palmer J, Pasquini MC, Rizzo JD, Saber W, Thomas M, Drobyski WR) Biol Blood Marrow Transplant 2013 Sep;19(9):1368-73 PMID: 23806770 06/29/2013
  • Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis. (Koreth J, Pidala J, Perez WS, Deeg HJ, Garcia-Manero G, Malcovati L, Cazzola M, Park S, Itzykson R, Ades L, Fenaux P, Jadersten M, Hellstrom-Lindberg E, Gale RP, Beach CL, Lee SJ, Horowitz MM, Greenberg PL, Tallman MS, DiPersio JF, Bunjes D, Weisdorf DJ, Cutler C) J Clin Oncol 2013 Jul 20;31(21):2662-70 PMID: 23797000 PMCID: PMC3825320 06/26/2013
  • Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. (Fernández-Viña MA, Klein JP, Haagenson M, Spellman SR, Anasetti C, Noreen H, Baxter-Lowe LA, Cano P, Flomenberg N, Confer DL, Horowitz MM, Oudshoorn M, Petersdorf EW, Setterholm M, Champlin R, Lee SJ, de Lima M) Blood 2013 May 30;121(22):4603-10 PMID: 23596045 PMCID: PMC3668493 04/19/2013
  • Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration. (Giralt S, McCarthy PL, Anderson KC, Carter SL, Richardson PG, Rajkumar SV, Laport GG, Stadtmauer EA, Pasquini MC, Horowitz MM) Biol Blood Marrow Transplant 2013 Jun;19(6):858-9 PMID: 23545332 PMCID: PMC4426902 04/03/2013
  • Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. (Gratwohl A, Baldomero H, Gratwohl M, Aljurf M, Bouzas LF, Horowitz M, Kodera Y, Lipton J, Iida M, Pasquini MC, Passweg J, Szer J, Madrigal A, Frauendorfer K, Niederwieser D, Worldwide Network of Blood and Marrow Transplantation (WBMT)) Haematologica 2013 Aug;98(8):1282-90 PMID: 23508009 PMCID: PMC3729910 03/20/2013
  • Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial. (Vose JM, Carter S, Burns LJ, Ayala E, Press OW, Moskowitz CH, Stadtmauer EA, Mineshi S, Ambinder R, Fenske T, Horowitz M, Fisher R, Tomblyn M) J Clin Oncol 2013 May 01;31(13):1662-8 PMID: 23478060 PMCID: PMC3635682 03/13/2013
  • Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation. (Petersdorf EW, Malkki M, Horowitz MM, Spellman SR, Haagenson MD, Wang T) Blood 2013 Mar 07;121(10):1896-905 PMID: 23305741 PMCID: PMC3591807 01/12/2013
  • 2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. (Pasquini M, Wang Z, Horowitz MM, Gale RP) Clin Transpl 2013:187-97 PMID: 25095508 01/01/2013
  • Cord-blood engraftment with ex vivo mesenchymal-cell coculture. (de Lima M, McNiece I, Robinson SN, Munsell M, Eapen M, Horowitz M, Alousi A, Saliba R, McMannis JD, Kaur I, Kebriaei P, Parmar S, Popat U, Hosing C, Champlin R, Bollard C, Molldrem JJ, Jones RB, Nieto Y, Andersson BS, Shah N, Oran B, Cooper LJ, Worth L, Qazilbash MH, Korbling M, Rondon G, Ciurea S, Bosque D, Maewal I, Simmons PJ, Shpall EJ) N Engl J Med 2012 Dec 13;367(24):2305-15 PMID: 23234514 PMCID: PMC3805360 12/14/2012
  • Does matched unrelated donor transplantation have the same outcome as matched sibling transplantation in unselected patients? (Horowitz MM) Best Pract Res Clin Haematol 2012 Dec;25(4):483-6 PMID: 23200546 12/04/2012
  • Peripheral-blood stem cells versus bone marrow from unrelated donors. (Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley SD, Bredeson C, Carter SL, Horowitz MM, Confer DL, Blood and Marrow Transplant Clinical Trials Network) N Engl J Med 2012 Oct 18;367(16):1487-96 PMID: 23075175 PMCID: PMC3816375 10/19/2012
  • Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. (Pasquini MC, Devine S, Mendizabal A, Baden LR, Wingard JR, Lazarus HM, Appelbaum FR, Keever-Taylor CA, Horowitz MM, Carter S, O'Reilly RJ, Soiffer RJ) J Clin Oncol 2012 Sep 10;30(26):3194-201 PMID: 22869882 PMCID: PMC3434978 08/08/2012
  • MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation. (Petersdorf EW, Malkki M, Gooley TA, Spellman SR, Haagenson MD, Horowitz MM, Wang T) Sci Transl Med 2012 Jul 25;4(144):144ra101 PMID: 22837536 PMCID: PMC3633562 07/28/2012
  • Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. (Rocha V, Spellman S, Zhang MJ, Ruggeri A, Purtill D, Brady C, Baxter-Lowe LA, Baudoux E, Bergamaschi P, Chow R, Freed B, Koegler G, Kurtzberg J, Larghero J, Lecchi L, Nagler A, Navarrette C, Prasad V, Pouthier F, Price T, Ratanatharathorn V, van Rood JJ, Horowitz MM, Gluckman E, Eapen M, Eurocord-European Blood and Marrow Transplant Group and the Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2012 Dec;18(12):1890-6 PMID: 22814031 PMCID: PMC3826155 07/21/2012
  • Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). (Halter JP, van Walraven SM, Worel N, Bengtsson M, Hägglund H, Nicoloso de Faveri G, Shaw BE, Schmidt AH, Fechter M, Madrigal A, Szer J, Aljurf MD, Weisdorf D, Horowitz MM, Greinix H, Niederwieser D, Gratwohl A, Kodera Y, Confer D) Bone Marrow Transplant 2013 Feb;48(2):220-5 PMID: 22773129 07/10/2012
  • Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. (Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M) Biol Blood Marrow Transplant 2012 Nov;18(11):1727-33 PMID: 22766220 PMCID: PMC3472079 07/07/2012
  • Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research. (Pasquini MC, Voltarelli J, Atkins HL, Hamerschlak N, Zhong X, Ahn KW, Sullivan KM, Carrum G, Andrey J, Bredeson CN, Cairo M, Gale RP, Hahn T, Storek J, Horowitz MM, McSweeney PA, Griffith LM, Muraro PA, Pavletic SZ, Nash RA) Biol Blood Marrow Transplant 2012 Oct;18(10):1471-8 PMID: 22705497 PMCID: PMC3950896 06/19/2012
  • A perspective on the selection of unrelated donors and cord blood units for transplantation. (Spellman SR, Eapen M, Logan BR, Mueller C, Rubinstein P, Setterholm MI, Woolfrey AE, Horowitz MM, Confer DL, Hurley CK, National Marrow Donor Program, Center for International Blood and Marrow Transplant Research) Blood 2012 Jul 12;120(2):259-65 PMID: 22596257 PMCID: PMC3398760 05/19/2012
  • Lenalidomide after stem-cell transplantation for multiple myeloma. (McCarthy PL, Owzar K, Hofmeister CC, Hurd DD, Hassoun H, Richardson PG, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, Isola L, Maziarz RT, Gabriel DA, Bashey A, Landau H, Martin T, Qazilbash MH, Levitan D, McClune B, Schlossman R, Hars V, Postiglione J, Jiang C, Bennett E, Barry S, Bressler L, Kelly M, Seiler M, Rosenbaum C, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Anderson KC, Linker C) N Engl J Med 2012 May 10;366(19):1770-81 PMID: 22571201 PMCID: PMC3744390 05/11/2012
  • No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation. (Tomblyn M, Chen M, Kukreja M, Aljurf MD, Al Mohareb F, Bolwell BJ, Cahn JY, Carabasi MH, Gale RP, Gress RE, Gupta V, Hale GA, Ljungman P, Maziarz RT, Storek J, Wingard JR, Young JA, Horowitz MM, Ballen KK) Transpl Infect Dis 2012 Oct;14(5):468-78 PMID: 22548788 PMCID: PMC3481161 05/03/2012
  • Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels. (Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID, Carter SL, Horowitz MM, Nakamura R, Pulsipher MA, Difronzo NL, Confer DL, Eapen M, Anderlini P) Biol Blood Marrow Transplant 2012 Jul;18(7):1007-11 PMID: 22546497 PMCID: PMC3677744 05/02/2012
  • Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. (Ballen KK, Woolfrey AE, Zhu X, Ahn KW, Wirk B, Arora M, George B, Savani BN, Bolwell B, Porter DL, Copelan E, Hale G, Schouten HC, Lewis I, Cahn JY, Halter J, Cortes J, Kalaycio ME, Antin J, Aljurf MD, Carabasi MH, Hamadani M, McCarthy P, Pavletic S, Gupta V, Deeg HJ, Maziarz RT, Horowitz MM, Saber W) Biol Blood Marrow Transplant 2012 Sep;18(9):1446-54 PMID: 22449610 PMCID: PMC3499973 03/28/2012
  • Two cases of transfusion-transmitted Anaplasma phagocytophilum. (Annen K, Friedman K, Eshoa C, Horowitz M, Gottschall J, Straus T) Am J Clin Pathol 2012 Apr;137(4):562-5 PMID: 22431531 03/21/2012
  • Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. (Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon JD, Dubois V, Horowitz MM, Madrigal JA, Morishima Y, Oudshoorn M, Ringden O, Spellman S, Velardi A, Zino E, Petersdorf EW, International Histocompatibility Working Group in Hematopoietic Cell Transplantation) Lancet Oncol 2012 Apr;13(4):366-74 PMID: 22340965 PMCID: PMC3813000 02/22/2012
  • Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. (Saber W, Opie S, Rizzo JD, Zhang MJ, Horowitz MM, Schriber J) Blood 2012 Apr 26;119(17):3908-16 PMID: 22327226 PMCID: PMC3350357 02/14/2012
  • Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. (Majhail NS, Brazauskas R, Hassebroek A, Bredeson CN, Hahn T, Hale GA, Horowitz MM, Lazarus HM, Maziarz RT, Wood WA, Parsons SK, Joffe S, Rizzo JD, Lee SJ, Hayes-Lattin BM) Biol Blood Marrow Transplant 2012 Jun;18(6):861-73 PMID: 22040843 PMCID: PMC3288160 11/02/2011
  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation. (Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang MJ, Antin JH, Bolwell BJ, Bredeson C, Cahn JY, Cairo M, Gale RP, Gupta V, Lee SJ, Litzow M, Weisdorf DJ, Horowitz MM, Hahn T) Blood 2012 Jan 05;119(1):296-307 PMID: 22010102 PMCID: PMC3251233 10/20/2011
  • Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis. (Khoury HJ, Kukreja M, Goldman JM, Wang T, Halter J, Arora M, Gupta V, Rizzieri DA, George B, Keating A, Gale RP, Marks DI, McCarthy PL, Woolfrey A, Szer J, Giralt SA, Maziarz RT, Cortes J, Horowitz MM, Lee SJ) Bone Marrow Transplant 2012 Jun;47(6):810-6 PMID: 21986636 PMCID: PMC3896981 10/12/2011
  • Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. (Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C, Brown M, Champlin RE, Garcia-Lopez J, Hattersely G, Koegler G, Laughlin MJ, Michel G, Nabhan SK, Smith FO, Horowitz MM, Gluckman E, Rocha V, Eurocord-European Group for Blood and Marrow Transplantation, Netcord, Center for International Blood and Marrow Transplant Research) Lancet Oncol 2011 Dec;12(13):1214-21 PMID: 21982422 PMCID: PMC3245836 10/11/2011
  • Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials. (Denzen EM, Santibáñez ME, Moore H, Foley A, Gersten ID, Gurgol C, Majhail NS, Spellecy R, Horowitz MM, Murphy EA) Biol Blood Marrow Transplant 2012 Feb;18(2):183-9 PMID: 21806948 PMCID: PMC3242929 10/05/2011
  • Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial. (Krishnan A, Pasquini MC, Logan B, Stadtmauer EA, Vesole DH, Alyea E 3rd, Antin JH, Comenzo R, Goodman S, Hari P, Laport G, Qazilbash MH, Rowley S, Sahebi F, Somlo G, Vogl DT, Weisdorf D, Ewell M, Wu J, Geller NL, Horowitz MM, Giralt S, Maloney DG, Blood Marrow Transplant Clinical Trials Network (BMT CTN)) Lancet Oncol 2011 Dec;12(13):1195-203 PMID: 21962393 PMCID: PMC3611089 10/04/2011
  • Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. (Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M, Cahn JY, Cairo MS, Herzig RH, Isola LM, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman SR, Weisdorf DJ, Wingard JR, Horowitz MM, Pavletic SZ) Blood 2011 Oct 20;118(16):4472-9 PMID: 21878671 PMCID: PMC3204914 09/01/2011
  • Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. (Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JC, Deeg HJ) Blood 2011 Sep 01;118(9):2618-21 PMID: 21677312 PMCID: PMC3167362 06/17/2011
  • Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. (Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola L, Jacobsohn DA, Jagasia M, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman S, Wingard JR, Horowitz MM, Pavletic SZ) Blood 2011 Jun 16;117(24):6714-20 PMID: 21493797 PMCID: PMC3123030 04/16/2011
  • Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. (Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M) Blood 2011 Jun 23;117(25):6963-70 PMID: 21464372 PMCID: PMC3128486 04/06/2011
  • Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. (Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, Horowitz MM, Bolwell B, Rizzo JD, Socié G) J Clin Oncol 2011 Jun 01;29(16):2230-9 PMID: 21464398 PMCID: PMC3107742 04/06/2011
  • Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007. (Ahmed SO, Ghavamzadeh A, Zaidi SZ, Baldomero H, Pasquini MC, Hussain F, Alimoghaddam K, Almohareb F, Ayas M, Hamidieh A, Mahmoud HK, Elhaddad A, Ben Othman T, Abdelkefi A, Sarhan M, Abdel-Rahman F, Adil S, Alkindi S, Bazarbachi A, Benchekroun S, Niederwieser D, Horowitz M, Gratwohl A, El Solh H, Aljurf M) Biol Blood Marrow Transplant 2011 Sep;17(9):1352-61 PMID: 21440654 PMCID: PMC3371191 03/29/2011
  • Alternative donor transplantation for aplastic anemia. (Eapen M, Horowitz MM) Hematology Am Soc Hematol Educ Program 2010;2010:43-6 PMID: 21239769 01/18/2011
  • Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and Medicaid Services. (Giralt SA, Horowitz M, Weisdorf D, Cutler C) J Clin Oncol 2011 Feb 10;29(5):566-72 PMID: 21220586 PMCID: PMC4874212 01/12/2011
  • Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials Network. (Horwitz EM, Horowitz MM, DiFronzo NL, Kohn DB, Heslop HE, Blood and Marrow Transplant Clinical Trials Network, State of the Science Cell and Gene Therapy Committee) Biol Blood Marrow Transplant 2011 Feb;17(2):192-6 PMID: 21182973 PMCID: PMC3387575 12/25/2010
  • Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response. (Tomblyn MR, Ewell M, Bredeson C, Kahl BS, Goodman SA, Horowitz MM, Vose JM, Negrin RS, Laport GG) Biol Blood Marrow Transplant 2011 Jul;17(7):1051-7 PMID: 21073974 PMCID: PMC3114272 11/16/2010
  • Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. (Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, DiFronzo N, Horowitz MM, Antin JH) Biol Blood Marrow Transplant 2011 Mar;17(3):291-9 PMID: 21034841 PMCID: PMC3053041 11/03/2010
  • Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. (Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, Bolwell B, Wingard JR, Socie G) Blood 2011 Jan 06;117(1):316-22 PMID: 20926773 PMCID: PMC3037753 10/12/2010
  • Factors associated with self-reported physical and mental health after hematopoietic cell transplantation. (Wingard JR, Huang IC, Sobocinski KA, Andrykowski MA, Cella D, Rizzo JD, Brady M, Horowitz MM, Bishop MM) Biol Blood Marrow Transplant 2010 Dec;16(12):1682-92 PMID: 20685400 PMCID: PMC2975785 08/06/2010
  • Access to hematopoietic stem cell transplantation: effect of race and sex. (Joshua TV, Rizzo JD, Zhang MJ, Hari PN, Kurian S, Pasquini M, Majhail NS, Lee SJ, Horowitz MM) Cancer 2010 Jul 15;116(14):3469-76 PMID: 20564154 PMCID: PMC3153958 06/22/2010
  • Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. (Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE, Center for International Blood and Marrow Transplant Research, Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation), National Cord Blood Program of the New York Blood Center) Lancet Oncol 2010 Jul;11(7):653-60 PMID: 20558104 PMCID: PMC3163510 06/19/2010
  • Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. (Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, Horowitz MM, Eapen M, Nagler A, Shpall EJ, Laughlin MJ, Daniely Y, Pacheco D, Barishev R, Olmer L, Freedman LS) Bone Marrow Transplant 2011 Jan;46(1):70-6 PMID: 20436518 PMCID: PMC3366187 05/04/2010
  • Hematopoietic stem cell transplantation: a global perspective. (Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, Szer J, Lipton J, Schwendener A, Gratwohl M, Frauendorfer K, Niederwieser D, Horowitz M, Kodera Y, Worldwide Network of Blood and Marrow Transplantation) JAMA 2010 Apr 28;303(16):1617-24 PMID: 20424252 PMCID: PMC3219875 04/29/2010
  • Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. (Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, Horowitz MM, Rizzo JD) J Clin Oncol 2010 Apr 10;28(11):1888-95 PMID: 20212247 PMCID: PMC2860369 03/10/2010
  • Unrelated hematopoietic stem cell donors as research subjects. (King RJ, Confer DL, Greinix HT, Halter J, Horowitz M, Schmidt AH, Costeas P, Shaw B, Egeland T, Ethics and Clinical Working Groups of World Marrow Donor Association) Bone Marrow Transplant 2011 Jan;46(1):10-3 PMID: 20190845 03/02/2010
  • Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products. (Hurley CK, Foeken L, Horowitz M, Lindberg B, McGregor M, Sacchi N, WMDA Accreditation and Regulatory Committees) Bone Marrow Transplant 2010 May;45(5):819-24 PMID: 20173794 02/23/2010
  • Re: An approach to predicting HSCT outcome using HLA-mismatch information mapped on protein structure data. (Hurley CK, Oudshoorn M, Setterholm M, Spellman SR, Petersdorf E, Lee SJ, Gooley T, Malkki M, Horowitz MM) Biol Blood Marrow Transplant 2010 Jun;16(6):865-6 PMID: 20172039 02/23/2010
  • Response to Letter from Demetrios S. Theodoropoulos, MD, DSc. (Gajewski JL, Lill M, Horowitz M, Maziarz RT) Biol Blood Marrow Transplant 2010 Apr;16(4):561-2 PMID: 20139024 02/09/2010
  • 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. (Pasquini MC, Wang Z, Horowitz MM, Gale RP) Clin Transpl 2010:87-105 PMID: 21696033 01/01/2010
  • Allogeneic hematopoietic cell transplant for prolymphocytic leukemia. (Kalaycio ME, Kukreja M, Woolfrey AE, Szer J, Cortes J, Maziarz RT, Bolwell BJ, Buser A, Copelan E, Gale RP, Gupta V, Maharaj D, Marks DI, Pavletic SZ, Horowitz MM, Arora M) Biol Blood Marrow Transplant 2010 Apr;16(4):543-7 PMID: 19961946 PMCID: PMC2839005 12/08/2009
  • High-resolution typing for unrelated donor transplantation: how far do we go? (Horowitz MM) Best Pract Res Clin Haematol 2009 Dec;22(4):537-41 PMID: 19959105 PMCID: PMC2904986 12/05/2009
  • Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation. (Shaughnessy PJ, Bolwell BJ, van Besien K, Mistrik M, Grigg A, Dodds A, Prince HM, Durrant S, Ilhan O, Parenti D, Gallo J, Foss F, Apperley J, Zhang MJ, Horowitz MM, Abhyankar S) Bone Marrow Transplant 2010 Jun;45(6):1068-76 PMID: 19915634 PMCID: PMC3376382 11/17/2009
  • Defining the intensity of conditioning regimens: working definitions. (Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M) Biol Blood Marrow Transplant 2009 Dec;15(12):1628-33 PMID: 19896087 PMCID: PMC2861656 11/10/2009
  • Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. (Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, Cervantes F, Deininger M, Gratwohl A, Guilhot F, Hochhaus A, Horowitz M, Hughes T, Kantarjian H, Larson R, Radich J, Simonsson B, Silver RT, Goldman J, Hehlmann R, European LeukemiaNet) J Clin Oncol 2009 Dec 10;27(35):6041-51 PMID: 19884523 PMCID: PMC4979100 11/04/2009
  • Outcome of transplantation for myelofibrosis. (Ballen KK, Shrestha S, Sobocinski KA, Zhang MJ, Bashey A, Bolwell BJ, Cervantes F, Devine SM, Gale RP, Gupta V, Hahn TE, Hogan WJ, Kröger N, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Schiller G, Schouten HC, Roy V, Wiernik PH, Horowitz MM, Giralt SA, Arora M) Biol Blood Marrow Transplant 2010 Mar;16(3):358-67 PMID: 19879949 PMCID: PMC2908949 11/03/2009
  • Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse. (Weisdorf DJ, Nelson G, Lee SJ, Haagenson M, Spellman S, Antin JH, Bolwell B, Cahn JY, Cervantes F, Copelan E, Gale R, Gratwohl A, Khoury HJ, McCarthy P, Marks DI, Szer J, Woolfrey A, Cortes-Franco J, Horowitz MM, Arora M, Chronic Leukemia Working Committee) Biol Blood Marrow Transplant 2009 Nov;15(11):1475-8 PMID: 19822308 PMCID: PMC2929002 10/14/2009
  • Impending challenges in the hematopoietic stem cell transplantation physician workforce. (Gajewski JL, LeMaistre CF, Silver SM, Lill MC, Selby GB, Horowitz MM, Rizzo JD, Heslop HE, Anasetti C, Maziarz RT) Biol Blood Marrow Transplant 2009 Dec;15(12):1493-501 PMID: 19781658 09/29/2009
  • Stem cell donation--what advice can be given to the donor? (Pamphilon D, Siddiq S, Brunskill S, Dorée C, Hyde C, Horowitz M, Stanworth S) Br J Haematol 2009 Oct;147(1):71-6 PMID: 19681886 PMCID: PMC3409390 08/18/2009
  • Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. (Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, Confer DL) Blood 2009 Sep 24;114(13):2606-16 PMID: 19608747 PMCID: PMC2756121 07/18/2009
  • HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. (Baxter-Lowe LA, Maiers M, Spellman SR, Haagenson MD, Wang T, Fernandez-Vina M, Marsh SG, Horowitz M, Hurley CK) Biol Blood Marrow Transplant 2009 Aug;15(8):971-81 PMID: 19589487 PMCID: PMC2747529 07/11/2009
  • Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research. (Gupta V, Tomblyn M, Pedersen TL, Atkins HL, Battiwalla M, Gress RE, Pollack MS, Storek J, Thompson JC, Tiberghien P, Young JA, Ribaud P, Horowitz MM, Keating A) Biol Blood Marrow Transplant 2009 Jul;15(7):864-71 PMID: 19539219 PMCID: PMC2881828 06/23/2009
  • Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. (Alousi AM, Weisdorf DJ, Logan BR, Bolaños-Meade J, Carter S, Difronzo N, Pasquini M, Goldstein SC, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, Levine JE, Blood and Marrow Transplant Clinical Trials Network) Blood 2009 Jul 16;114(3):511-7 PMID: 19443659 PMCID: PMC2713466 05/16/2009
  • Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. (Lazarus HM, Kan F, Tarima S, Champlin RE, Confer DL, Frey N, Gee AP, Wagner JE, Horowitz MM, Eapen M) Biol Blood Marrow Transplant 2009 May;15(5):589-96 PMID: 19361751 PMCID: PMC2688780 04/14/2009
  • Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation. (Ratanatharathorn V, Logan B, Wang D, Horowitz M, Uberti JP, Ringden O, Gale RP, Khoury H, Arora M, Spellman S, Cutler C, Antin J, Bornhaüser M, Hale G, Verdonck L, Cairo M, Gupta V, Pavletic S, Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA) Br J Haematol 2009 Jun;145(6):816-24 PMID: 19344418 PMCID: PMC3355660 04/07/2009
  • Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. (Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE) Blood 2009 May 14;113(20):4992-5001 PMID: 19264919 PMCID: PMC2686146 03/07/2009
  • HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. (Arora M, Weisdorf DJ, Spellman SR, Haagenson MD, Klein JP, Hurley CK, Selby GB, Antin JH, Kernan NA, Kollman C, Nademanee A, McGlave P, Horowitz MM, Petersdorf EW) J Clin Oncol 2009 Apr 01;27(10):1644-52 PMID: 19224849 PMCID: PMC2668970 02/20/2009
  • Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. (Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B) Biol Blood Marrow Transplant 2009 Mar;15(3):367-9 PMID: 19203728 PMCID: PMC3110087 02/11/2009
  • Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. (Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL) Blood 2009 Apr 09;113(15):3604-11 PMID: 19190248 PMCID: PMC2668845 02/05/2009
  • The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. (Ringdén O, Pavletic SZ, Anasetti C, Barrett AJ, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C, Cairo MS, Gale RP, Gupta V, Hahn T, Hale GA, Halter J, Jagasia M, Litzow MR, Locatelli F, Marks DI, McCarthy PL, Cowan MJ, Petersdorf EW, Russell JA, Schiller GJ, Schouten H, Spellman S, Verdonck LF, Wingard JR, Horowitz MM, Arora M) Blood 2009 Mar 26;113(13):3110-8 PMID: 19059878 PMCID: PMC2662650 12/09/2008
  • Unrelated donor hematopoietic cell transplantation: factors associated with a better HLA match. (Dehn J, Arora M, Spellman S, Setterholm M, Horowitz M, Confer D, Weisdorf D) Biol Blood Marrow Transplant 2008 Dec;14(12):1334-40 PMID: 19041054 PMCID: PMC3319684 12/02/2008
  • Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). (Lazarus HM, Carreras J, Boudreau C, Loberiza FR Jr, Armitage JO, Bolwell BJ, Freytes CO, Gale RP, Gibson J, Hale GA, Inwards DJ, LeMaistre CF, Maharaj D, Marks DI, Miller AM, Pavlovsky S, Schouten HC, van Besien K, Vose JM, Bitran JD, Khouri IF, McCarthy PL, Yu H, Rowlings P, Serna DS, Horowitz MM, Rizzo JD, Center For International Blood & Marrow Transplant Research (CIBMTR)) Biol Blood Marrow Transplant 2008 Dec;14(12):1323-33 PMID: 19041053 PMCID: PMC2638759 12/02/2008
  • Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report. (Aljurf MD, Zaidi SZ, El Solh H, Hussain F, Ghavamzadeh A, Mahmoud HK, Shamsi T, Othman TB, Sarhan MM, Dennison D, Ibrahim A, Benchekroun S, Chaudhri N, Labar B, Horowitz M, Niederwieser D, Gratwohl A) Bone Marrow Transplant 2009 Jan;43(1):1-12 PMID: 19043456 PMCID: PMC3351791 12/02/2008
  • Use of biological assignment in hematopoietic stem cell transplantation clinical trials. (Logan B, Leifer E, Bredeson C, Horowitz M, Ewell M, Carter S, Geller N) Clin Trials 2008;5(6):607-16 PMID: 19029209 PMCID: PMC2671015 11/26/2008
  • Solid cancers after allogeneic hematopoietic cell transplantation. (Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers ME, Friedman DL, Horowitz MM, Wingard JR, Deeg HJ) Blood 2009 Jan 29;113(5):1175-83 PMID: 18971419 PMCID: PMC2635083 10/31/2008
  • The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research. (Horowitz M) Bone Marrow Transplant 2008 Aug;42 Suppl 1:S1-S2 PMID: 18724277 09/25/2008
  • Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. (Cutler C, Stevenson K, Kim HT, Richardson P, Ho VT, Linden E, Revta C, Ebert R, Warren D, Choi S, Koreth J, Armand P, Alyea E, Carter S, Horowitz M, Antin JH, Soiffer R) Blood 2008 Dec 01;112(12):4425-31 PMID: 18776081 PMCID: PMC2597119 09/09/2008
  • Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. (Bredeson CN, Zhang MJ, Agovi MA, Bacigalupo A, Bahlis NJ, Ballen K, Brown C, Chaudhry MA, Horowitz MM, Kurian S, Quinlan D, Muehlenbien CE, Russell JA, Savoie L, Rizzo JD, Stewart DA) Biol Blood Marrow Transplant 2008 Sep;14(9):993-1003 PMID: 18721762 PMCID: PMC3321981 08/30/2008
  • HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors. (Duquesnoy R, Spellman S, Haagenson M, Wang T, Horowitz MM, Oudshoorn M) Biol Blood Marrow Transplant 2008 Sep;14(9):1064-71 PMID: 18721770 PMCID: PMC2572684 08/30/2008
  • Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. (Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP, Halter J, Keating A, Marks DI, McCarthy PL, Olavarria E, Stadtmauer EA, Abecasis M, Gupta V, Khoury HJ, George B, Hale GA, Liesveld JL, Rizzieri DA, Antin JH, Bolwell BJ, Carabasi MH, Copelan E, Ilhan O, Litzow MR, Schouten HC, Zander AR, Horowitz MM, Maziarz RT) Blood 2008 Oct 15;112(8):3500-7 PMID: 18664621 PMCID: PMC2954751 07/31/2008
  • Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. (Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C, Setterholm M, Drexler R, Maiers M, King R, Confer D, Klein J) Biol Blood Marrow Transplant 2008 Jul;14(7):748-58 PMID: 18541193 PMCID: PMC2668157 06/11/2008
  • Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population. (Levine JE, Barrett AJ, Zhang MJ, Arora M, Pulsipher MA, Bunin N, Fort J, Loberiza F, Porter D, Giralt S, Drobyski W, Wang D, Pavletic S, Ringden O, Horowitz MM, Collins R Jr) Bone Marrow Transplant 2008 Aug;42(3):201-5 PMID: 18490913 05/21/2008
  • On the probability of using cord blood. (Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM) Biol Blood Marrow Transplant 2008 Jun;14(6):724-5 PMID: 18489999 05/21/2008
  • Use of cost-effectiveness analysis to determine inventory size for a national cord blood bank. (Howard DH, Meltzer D, Kollman C, Maiers M, Logan B, Gragert L, Setterholm M, Horowitz MM) Med Decis Making 2008 Mar-Apr;28(2):243-53 PMID: 18349441 03/20/2008
  • Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. (Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM) Biol Blood Marrow Transplant 2008 Mar;14(3):316-22 PMID: 18275898 PMCID: PMC2531159 02/16/2008
  • HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. (Schlenk RF, Pasquini MC, Pérez WS, Zhang MJ, Krauter J, Antin JH, Bashey A, Bolwell BJ, Büchner T, Cahn JY, Cairo MS, Copelan EA, Cutler CS, Döhner H, Gale RP, Ilhan O, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Nimer SD, Sierra J, Tallman MS, Weisdorf DJ, Horowitz MM, Ganser A, CIBMTR Acute Leukemia Working Committee) Biol Blood Marrow Transplant 2008 Feb;14(2):187-96 PMID: 18215779 PMCID: PMC2531160 01/25/2008
  • Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. (Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn JY, Lazarus HM, Litzow MR, Marks DI, Wiernik PH, McCarthy PL, Russell JA, Miller CB, Sierra J, Milone G, Keating A, Loberiza FR Jr, Giralt S, Horowitz MM, Weisdorf DJ) Bone Marrow Transplant 2008 Apr;41(7):635-42 PMID: 18084335 PMCID: PMC2587442 12/18/2007
  • Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. (Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ, Wingard JR, Rowley SD, Stroncek D, Gee AP, Horowitz MM, Anasetti C) Biol Blood Marrow Transplant 2007 Dec;13(12):1461-8 PMID: 18022576 PMCID: PMC2267869 11/21/2007
  • Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007. (Ferrara JL, Anasetti C, Stadtmauer E, Antin J, Wingard J, Lee S, Levine J, Schultz K, Appelbaum F, Negrin R, Giralt S, Bredeson C, Heslop H, Horowitz M) Biol Blood Marrow Transplant 2007 Nov;13(11):1268-85 PMID: 17950914 10/24/2007
  • High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. (Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, Fernandez-Vina M, Flomenberg N, Horowitz M, Hurley CK, Noreen H, Oudshoorn M, Petersdorf E, Setterholm M, Spellman S, Weisdorf D, Williams TM, Anasetti C) Blood 2007 Dec 15;110(13):4576-83 PMID: 17785583 09/06/2007
  • The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. (Shaw BE, Gooley TA, Malkki M, Madrigal JA, Begovich AB, Horowitz MM, Gratwohl A, Ringdén O, Marsh SG, Petersdorf EW) Blood 2007 Dec 15;110(13):4560-6 PMID: 17726164 08/30/2007
  • Mapping MHC-resident transplantation determinants. (Malkki M, Gooley TA, Horowitz MM, Absi L, Christiansen FT, Cornelissen JJ, Dormoy A, Dubois V, Gagne K, Gluckman E, Haagenson MD, Oudshoorn M, Spellman S, Petersdorf EW, International Histocompatibility Working Group in Transplantation) Biol Blood Marrow Transplant 2007 Aug;13(8):986-95 PMID: 17640603 PMCID: PMC3182140 07/21/2007
  • Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. (Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE) Lancet 2007 Jun 09;369(9577):1947-54 PMID: 17560447 06/15/2007
  • Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia. (Giralt SA, Arora M, Goldman JM, Lee SJ, Maziarz RT, McCarthy PL, Sobocinski KA, Horowitz MM, Chronic Leukemia Working Committee, Center for International Blood and Marrow Transplant Research) Br J Haematol 2007 Jun;137(5):461-7 PMID: 17459051 04/27/2007
  • Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. (Petersdorf EW, Gooley T, Malkki M, Horowitz M, International Histocompatibility Working Group in Hematopoietic Cell Transplantation) Tissue Antigens 2007 Apr;69 Suppl 1:25-30 PMID: 17445158 04/21/2007
  • MHC class I, II, and III microsatellite marker matching and survival in unrelated donor hematopoietic cell transplantation. (Malkki M, Gooley T, Horowitz M, Petersdorf EW, IHWG HCT Component) Tissue Antigens 2007 Apr;69 Suppl 1:46-9 PMID: 17445162 04/21/2007
  • Immune response gene polymorphisms in unrelated donor hematopoietic cell transplantation. (Malkki M, Gooley T, Dubois V, Horowitz M, Petersdorf EW) Tissue Antigens 2007 Apr;69 Suppl 1:50-3 PMID: 17445163 04/21/2007
  • Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. (Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR) J Clin Oncol 2007 Apr 10;25(11):1403-11 PMID: 17416860 04/10/2007
  • Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. (Miller JS, Cooley S, Parham P, Farag SS, Verneris MR, McQueen KL, Guethlein LA, Trachtenberg EA, Haagenson M, Horowitz MM, Klein JP, Weisdorf DJ) Blood 2007 Jun 01;109(11):5058-61 PMID: 17317850 PMCID: PMC1885526 02/24/2007
  • Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions. (Weisdorf D, Carter S, Confer D, Ferrara J, Horowitz M) Biol Blood Marrow Transplant 2007 Mar;13(3):257-62; discussion 255-6 PMID: 17317578 02/24/2007
  • Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. (Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E, Bredeson CN, Eapen M, Horowitz MM) Blood 2007 May 15;109(10):4582-5 PMID: 17272503 PMCID: PMC1885491 02/03/2007
  • Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. (Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD, Loberiza FR, Gratwohl A, Champlin RE, International Bone Marrow Transplant Registry, European Group for Blood and Marrow Transplantation) Blood 2006 Dec 15;108(13):4288-90 PMID: 16946302 PMCID: PMC1895450 09/02/2006
  • Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. (Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM, Loberiza FR, Porter DL) Biol Blood Marrow Transplant 2006 Jul;12(7):758-69 PMID: 16785065 06/21/2006
  • Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. (Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, Apperley J, Cervantes F, Cortes J, Deininger M, Gratwohl A, Guilhot F, Horowitz M, Hughes T, Kantarjian H, Larson R, Niederwieser D, Silver R, Hehlmann R, European LeukemiaNet) Blood 2006 Sep 15;108(6):1809-20 PMID: 16709930 05/20/2006
  • A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. (Marks DI, Forman SJ, Blume KG, Pérez WS, Weisdorf DJ, Keating A, Gale RP, Cairo MS, Copelan EA, Horan JT, Lazarus HM, Litzow MR, McCarthy PL, Schultz KR, Smith DD, Trigg ME, Zhang MJ, Horowitz MM) Biol Blood Marrow Transplant 2006 Apr;12(4):438-53 PMID: 16545728 03/21/2006
  • Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. (Passweg JR, Pérez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W, Hows JM, Marsh JC, Pasquini R, Schrezenmeier H, Socié G, Zhang MJ, Bredeson C) Bone Marrow Transplant 2006 Apr;37(7):641-9 PMID: 16489361 02/21/2006
  • Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research. (Lazarus HM, Pérez WS, Klein JP, Kollman C, Bate-Boyle B, Bredeson CN, Gale RP, Geller RB, Keating A, Litzow MR, Marks DI, Miller CB, Douglas Rizzo J, Spitzer TR, Weisdorf DJ, Zhang MJ, Horowitz MM) Br J Haematol 2006 Mar;132(6):755-69 PMID: 16487177 02/21/2006
  • Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. (Tallman MS, Pérez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, García JJ, Ilhan O, Laughlin MJ, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Russell JA, Saez RA, Schiller G, Sierra J, Weiner RS, Zander AR, Zhang MJ, Keating A, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2006 Feb;12(2):204-16 PMID: 16443518 01/31/2006
  • Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. (Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS, Davies SM, Doyle JJ, Kurtzberg J, Pulsipher MA, Ortega JJ, Scaradavou A, Horowitz MM, Wagner JE) J Clin Oncol 2006 Jan 01;24(1):145-51 PMID: 16382124 12/31/2005
  • ABO blood group barrier in allogeneic bone marrow transplantation revisited. (Seebach JD, Stussi G, Passweg JR, Loberiza FR Jr, Gajewski JL, Keating A, Goerner M, Rowlings PA, Tiberghien P, Elfenbein GJ, Gale RP, van Rood JJ, Reddy V, Gluckman E, Bolwell BJ, Klumpp TR, Horowitz MM, Ringdén O, Barrett AJ, GVHD Working Committee of Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2005 Dec;11(12):1006-13 PMID: 16338623 12/13/2005
  • Evaluation of hematopoietic stem cell donors. (Horowitz MM, Confer DL) Hematology Am Soc Hematol Educ Program 2005:469-75 PMID: 16304422 11/24/2005
  • 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. (Pagel JM, Appelbaum FR, Eary JF, Rajendran J, Fisher DR, Gooley T, Ruffner K, Nemecek E, Sickle E, Durack L, Carreras J, Horowitz MM, Press OW, Gopal AK, Martin PJ, Bernstein ID, Matthews DC) Blood 2006 Mar 01;107(5):2184-91 PMID: 16254140 PMCID: PMC1895719 10/29/2005
  • Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. (Khoury HJ, Loberiza FR Jr, Ringdén O, Barrett AJ, Bolwell BJ, Cahn JY, Champlin RE, Gale RP, Hale GA, Urbano-Ispizua A, Martino R, McCarthy PL, Tiberghien P, Verdonck LF, Horowitz MM) Blood 2006 Feb 15;107(4):1712-6 PMID: 16239431 PMCID: PMC1895414 10/22/2005
  • Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. (Baker KS, Loberiza FR Jr, Yu H, Cairo MS, Bolwell BJ, Bujan-Boza WA, Camitta BM, Garcia JJ, Ho WG, Liesveld JL, Maharaj D, Marks DI, Schultz KR, Wiernik P, Zander AR, Horowitz MM, Keating A, Weisdorf DJ) J Clin Oncol 2005 Oct 01;23(28):7032-42 PMID: 16145067 09/08/2005
  • Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. (Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, Ferrara J, Soiffer R, Giralt S) Biol Blood Marrow Transplant 2005 Aug;11(8):571-5 PMID: 16041306 07/26/2005
  • Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. (Santo Tomas LH, Loberiza FR Jr, Klein JP, Layde PM, Lipchik RJ, Rizzo JD, Bredeson CN, Horowitz MM) Chest 2005 Jul;128(1):153-61 PMID: 16002929 07/09/2005
  • Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. (Cahn JY, Klein JP, Lee SJ, Milpied N, Blaise D, Antin JH, Leblond V, Ifrah N, Jouet JP, Loberiza F, Ringden O, Barrett AJ, Horowitz MM, Socié G, Société Française de Greffe de Moëlle et Thérapie Cellulaire, Dana Farber Cancer Institute, International Bone Marrow Transplant Registry) Blood 2005 Aug 15;106(4):1495-500 PMID: 15878974 PMCID: PMC1895210 05/10/2005
  • Immune therapy of chronic myelogenous leukemia. (Gale RP, Horowitz MM, Talpaz M, Scheinberg DA, Molldrem J, Li Z, Baccarani M, Goldman JM, Tura S) Leuk Res 2005 May;29(5):583-6 PMID: 15755511 03/10/2005
  • Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. (Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, O'Reilly RJ, Horowitz MM, Dupont B) Blood 2005 Jun 15;105(12):4878-84 PMID: 15731175 PMCID: PMC1894998 02/26/2005
  • Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. (Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ) Blood 2005 May 15;105(10):3802-11 PMID: 15687239 PMCID: PMC1895092 02/03/2005
  • Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. (Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR) J Clin Oncol 2005 Jan 20;23(3):599-608 PMID: 15659507 01/22/2005
  • Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. (Loberiza FR Jr, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS, Eapen M, Bredeson CN, Horowitz MM, Rizzo JD) Blood 2005 Apr 01;105(7):2979-87 PMID: 15598815 12/16/2004
  • Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. (Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM) N Engl J Med 2004 Nov 25;351(22):2265-75 PMID: 15564543 11/27/2004
  • Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. (Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza FR Jr, Ringdén O, Wagner JE) J Clin Oncol 2004 Dec 15;22(24):4872-80 PMID: 15520055 11/03/2004
  • Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. (Oh H, Loberiza FR Jr, Zhang MJ, Ringdén O, Akiyama H, Asai T, Miyawaki S, Okamoto S, Horowitz MM, Antin JH, Bashey A, Bird JM, Carabasi MH, Fay JW, Gale RP, Giller RH, Goldman JM, Hale GA, Harris RE, Henslee-Downey J, Kolb HJ, Litzow MR, McCarthy PL, Neudorf SM, Serna DS, Socié G, Tiberghien P, Barrett AJ) Blood 2005 Feb 15;105(4):1408-16 PMID: 15486071 10/16/2004
  • Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. (Godder K, Eapen M, Laver JH, Zhang MJ, Camitta BM, Wayne AS, Gale RP, Doyle JJ, Yu LC, Chen AR, Garvin JH Jr, Sandler ES, Yeager AM, Edwards JR, Horowitz MM) J Clin Oncol 2004 Sep 15;22(18):3798-804 PMID: 15365077 09/15/2004
  • Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. (Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M) Bone Marrow Transplant 2004 Oct;34(8):721-7 PMID: 15322568 08/24/2004
  • Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. (Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, Tsai T, Zhang MJ, Vose JM, Lazarus HM, van Besien K, Lymphoma Working Committee of the International Bone Marrow Transplant Registry) Blood 2004 Dec 01;104(12):3797-803 PMID: 15280203 07/29/2004
  • Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantation. (Lee SJ, Joffe S, Kim HT, Socie G, Gilman AL, Wingard JR, Horowitz MM, Cella D, Syrjala KL) Blood 2004 Oct 01;104(7):2194-200 PMID: 15198954 06/17/2004
  • Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. (Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, Hurley C, Kollman C, Anasetti C, Noreen H, Begovich A, Hildebrand W, Petersdorf E, Schmeckpeper B, Setterholm M, Trachtenberg E, Williams T, Yunis E, Weisdorf D) Blood 2004 Oct 01;104(7):1923-30 PMID: 15191952 06/12/2004
  • Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants. (Passweg JR, Walker I, Sobocinski KA, Klein JP, Horowitz MM, Giralt SA, Chronic Leukemia Study Writing Committee of the International Bone Marrow Transplant Registry) Br J Haematol 2004 Jun;125(5):613-20 PMID: 15147377 05/19/2004
  • A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. (Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, Schultz KR, Trigg ME, Keating A, Weisdorf DJ, Antin JH, Horowitz MM) Blood 2004 Jul 15;104(2):579-85 PMID: 15039286 03/25/2004
  • Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. (Vose JM, Rizzo DJ, Tao-Wu J, Armitage JO, Bashey A, Burns LJ, Christiansen NP, Freytes CO, Gale RP, Gibson J, Giralt SA, Herzig RH, Lemaistre CF, McCarthy PL Jr, Nimer SD, Petersen FB, Schenkein DP, Wiernik PH, Wiley JM, Loberiza FR, Lazarus HM, van Biesen K, Horowitz MM) Biol Blood Marrow Transplant 2004 Feb;10(2):116-27 PMID: 14750077 01/30/2004
  • Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation. (Khoury H, Trinkaus K, Zhang MJ, Adkins D, Brown R, Vij R, Goodnough LT, Ma MK, McLeod HL, Shenoy S, Horowitz M, Dipersio JF) Biol Blood Marrow Transplant 2003 Nov;9(11):714-21 PMID: 14652855 12/04/2003
  • Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. (Serna DS, Lee SJ, Zhang MJ, Baker kS, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR Jr) J Clin Oncol 2003 Oct 15;21(20):3754-60 PMID: 14551294 10/11/2003
  • Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. (Bierman PJ, Sweetenham JW, Loberiza FR Jr, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz M, Goldstone A, Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation) J Clin Oncol 2003 Oct 15;21(20):3744-53 PMID: 12963703 09/10/2003
  • Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. (van Besien K, Loberiza FR Jr, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, Freytes CO, Gibson J, Horowitz MM, Inwards DJ, Marks DI, Martino R, Maziarz RT, Molina A, Pavlovsky S, Pecora AL, Schouten HC, Shea TC, Lazarus HM, Rizzo JD, Vose JM) Blood 2003 Nov 15;102(10):3521-9 PMID: 12893748 08/02/2003
  • Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer. (Rizzo JD, Williams S, Wu JT, Pecora AL, Lazarus HM, Bolwell B, Fields KK, Gale RP, Elfenbein G, Horowitz MM, Antman KH) Bone Marrow Transplant 2003 Jul;32(2):151-5 PMID: 12838279 07/03/2003
  • Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. (Ringdén O, Barrett AJ, Zhang MJ, Loberiza FR, Bolwell BJ, Cairo MS, Gale RP, Hale GA, Litzow MR, Martino R, Russell JA, Tiberghien P, Urbano-Ispizua A, Horowitz MM) Br J Haematol 2003 Jun;121(6):874-85 PMID: 12786798 06/06/2003
  • Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. (Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S, Piantadosi S, Guthrie KA, Lynch JC, Takatu A, Horowitz MM, Antin JH, Weisdorf DJ, Martin PJ, Vogelsang GB) Blood 2003 Aug 01;102(3):802-9 PMID: 12714524 04/26/2003
  • Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know? (Loberiza FR Jr, Serna DS, Horowitz MM, Rizzo JD) Bone Marrow Transplant 2003 Mar;31(6):417-21 PMID: 12665834 04/01/2003
  • Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries. (Vandenberghe E, Ruiz de Elvira C, Loberiza FR, Conde E, López-Guillermo A, Gisselbrecht C, Guilhot F, Vose JM, van Biesen K, Rizzo JD, Weisenburger DD, Isaacson P, Horowitz MM, Goldstone AH, Lazarus HM, Schmitz N) Br J Haematol 2003 Mar;120(5):793-800 PMID: 12614212 03/05/2003
  • Access to stem cell transplantation: do women fare as well as men? (Mehta P, Pollock BH, Nugent M, Horowitz M, Wingard JR) Am J Hematol 2003 Feb;72(2):99-102 PMID: 12555212 01/30/2003
  • Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. (Litzow MR, Pérez WS, Klein JP, Bolwell BJ, Camitta B, Copelan EA, Gale RP, Giralt SA, Keating A, Lazarus HM, Marks DI, McCarthy PL, Miller CB, Milone G, Prentice HG, Russell JA, Schultz KR, Trigg ME, Weisdorf DJ, Horowitz MM) Br J Haematol 2002 Dec;119(4):1115-24 PMID: 12472596 12/11/2002
  • A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. (Levine JE, Harris RE, Loberiza FR Jr, Armitage JO, Vose JM, Van Besien K, Lazarus HM, Horowitz MM, Bashey A, Bolwell BJ, Burns LJ, Cairo MS, Champlin RE, Freytes CO, Gibson J, Goldstein SC, Laughlin MJ, Lister J, Marks DI, Maziarz RT, Miller AM, Milone GA, Pavlovsky S, Pecora AL, Rizzo JD, Schiller G, Schouten HC, Zhang MJ, Lymphoma Study Writing Committee, International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry) Blood 2003 Apr 01;101(7):2476-82 PMID: 12456505 11/29/2002
  • The international bone marrow transplant registry. (Goldman JM, Horowitz MM) Int J Hematol 2002 Aug;76 Suppl 1:393-7 PMID: 12430889 11/15/2002
  • Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. (Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, Williams SF, Li CY, Travis LB, Weisdorf DJ) Blood 2003 Mar 01;101(5):2015-23 PMID: 12393427 10/24/2002
  • Conference synopsis: hematopoietic stem cell therapy in autoimmune diseases, October 2001. Biol Blood Marrow Transplant 2002;8(8):407-11 PMID: 12234165 09/18/2002
  • Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. (Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, Canals C, Boogaerts MA, Goldman J, Champlin RE, Keating A, Weisdorf DJ, de Witte TM, Horowitz MM) Blood 2002 Sep 15;100(6):1997-2004 PMID: 12200358 08/30/2002
  • Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. (Bellm LA, Cunningham G, Durnell L, Eilers J, Epstein JB, Fleming T, Fuchs HJ, Haskins MN, Horowitz MM, Martin PJ, McGuire DB, Mullane K, Oster G) Cancer Invest 2002;20(5-6):793-800 PMID: 12197238 08/29/2002
  • Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantation. (Martin PJ, Antin JH, Weisdorf DJ, Paton V, Horowitz MM) Biol Blood Marrow Transplant 2002;8(6):295-302 PMID: 12108915 07/11/2002
  • Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. (Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY, Carabasi MH, Gale RP, Giralt S, Hale GA, Ilhan O, McCarthy PL, Socie G, Verdonck LF, Weisdorf DJ, Horowitz MM) Blood 2002 Jul 15;100(2):406-14 PMID: 12091329 07/02/2002
  • Autologous stem cell transplantation for small cell lung cancer. (Rizzo JD, Elias AD, Stiff PJ, Lazarus HM, Zhang MJ, Oblon DJ, Pecora AL, Hale GA, Horowitz MM) Biol Blood Marrow Transplant 2002;8(5):273-80 PMID: 12064365 06/18/2002
  • Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. (Weisdorf D, Bishop M, Dharan B, Bolwell B, Cahn JY, Cairo M, Giralt S, Klein J, Lazarus H, Litzow M, Marks D, McCarthy P, Miller C, Milone G, Russell J, Schultz KR, Sierra J, Wiernik P, Keating A, Loberiza F, Kollman C, Horowitz M) Biol Blood Marrow Transplant 2002;8(4):213-20 PMID: 12014810 05/17/2002
  • Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. (Loberiza FR Jr, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ) J Clin Oncol 2002 Apr 15;20(8):2118-26 PMID: 11956273 04/17/2002
  • Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. (van Rood JJ, Loberiza FR Jr, Zhang MJ, Oudshoorn M, Claas F, Cairo MS, Champlin RE, Gale RP, Ringdén O, Hows JM, Horowitz MH) Blood 2002 Mar 01;99(5):1572-7 PMID: 11861270 02/28/2002
  • A survey of diagnosis, management, and grading of chronic GVHD. (Lee SJ, Vogelsang G, Gilman A, Weisdorf DJ, Pavletic S, Antin JH, Horowitz MM, Akpek G, Flowers ME, Couriel D, Martin PJ) Biol Blood Marrow Transplant 2002;8(1):32-9 PMID: 11846354 02/16/2002
  • High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. (Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy PL Jr, Norton L, Parnes H, Pecora A, Perry MC, Rowlings P, Spitzer G, Horowitz MM) J Clin Oncol 2002 Feb 01;20(3):743-50 PMID: 11821456 02/01/2002
  • Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. (Levine JE, Braun T, Penza SL, Beatty P, Cornetta K, Martino R, Drobyski WR, Barrett AJ, Porter DL, Giralt S, Leis J, Holmes HE, Johnson M, Horowitz M, Collins RH Jr) J Clin Oncol 2002 Jan 15;20(2):405-12 PMID: 11786567 01/12/2002
  • The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase. (Lee SJ, Klein JP, Anasetti C, Antin JH, Loberiza FR, Bolwell BJ, LeMaistre CF, Litzow MR, Marks D, Waller EK, Matlack M, Giralt S, Horowitz MM) Blood 2001 Dec 01;98(12):3205-11 PMID: 11719355 11/24/2001
  • The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. (Miller CB, Rowlings PA, Zhang MJ, Jones RJ, Piantadosi S, Keating A, Armitage JO, Calderwood S, Harris RE, Klein JP, Lazarus HM, Linker CA, Sobocinski KA, Weisdorf D, Horowitz MM) Exp Hematol 2001 Nov;29(11):1336-46 PMID: 11698130 11/08/2001
  • Multi-state models and outcome prediction in bone marrow transplantation. (Keiding N, Klein JP, Horowitz MM) Stat Med 2001 Jun 30;20(12):1871-85 PMID: 11406847 06/15/2001
  • Transplant registries: guiding clinical decisions and improving outcomes. (Horowitz MM, Loberiza FR, Bredeson CN, Rizzo JD, Nugent ML) Oncology (Williston Park) 2001 May;15(5):649-59; discussion 663-4, 666 PMID: 11396358 06/09/2001
  • Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. (Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM, IBMTR Statistical Center of the International Bone Marrow Transplant Registry, Medical College of Wisconcin, Milwaukee, WI, USA, EBMT, Kiel, Germany) Bone Marrow Transplant 2001 Apr;27(7):689-92 PMID: 11360107 05/22/2001
  • Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). (Lazarus HM, Loberiza FR Jr, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM) Bone Marrow Transplant 2001 Feb;27(4):387-96 PMID: 11313668 04/21/2001
  • Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. (Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M) J Clin Oncol 2001 Apr 15;19(8):2201-5 PMID: 11304772 04/17/2001
  • Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. (Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ, Casper JT, Cowan MJ, Edwards JR, Fasth A, Gale RP, Junker A, Kamani NR, Loechelt BJ, Pietryga DW, Ringdén O, Vowels M, Hegland J, Williams AV, Klein JP, Sobocinski KA, Rowlings PA, Horowitz MM) Blood 2001 Mar 15;97(6):1598-603 PMID: 11238097 03/10/2001
  • Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. (Vose JM, Zhang MJ, Rowlings PA, Lazarus HM, Bolwell BJ, Freytes CO, Pavlovsky S, Keating A, Yanes B, van Besien K, Armitage JO, Horowitz MM, Autologous Blood and Marrow Transplant Registry Lymphoma Working Committee) J Clin Oncol 2001 Jan 15;19(2):406-13 PMID: 11208832 02/24/2001
  • Donor leukocyte infusions in acute lymphocytic leukemia. (Collins RH Jr, Goldstein S, Giralt S, Levine J, Porter D, Drobyski W, Barrett J, Johnson M, Kirk A, Horowitz M, Parker P) Bone Marrow Transplant 2000 Sep;26(5):511-6 PMID: 11019840 10/06/2000
  • High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report. (Stiff PJ, Veum-Stone J, Lazarus HM, Ayash L, Edwards JR, Keating A, Klein JP, Oblon DJ, Shea TC, Thomé S, Horowitz MM) Ann Intern Med 2000 Oct 03;133(7):504-15 PMID: 11015163 10/03/2000
  • Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. (Tallman MS, Rowlings PA, Milone G, Zhang MJ, Perez WS, Weisdorf D, Keating A, Gale RP, Geller RB, Laughlin MJ, Lazarus HM, Luger SM, McCarthy PL, Rowe JM, Saez RA, Vowels MR, Horowitz MM) Blood 2000 Aug 15;96(4):1254-8 PMID: 10942365 08/15/2000
  • Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. (Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E) N Engl J Med 2000 Jun 22;342(25):1846-54 PMID: 10861319 06/22/2000
  • Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). (Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, Gale RP, Goldman JM, Loberiza FR Jr, Hertenstein B, Klein JP, Montserrat E, Zhang MJ, Ringdén O, Tomany SC, Rowlings PA, Van Hoef ME, Gratwohl A) Blood 2000 Jun 15;95(12):3702-9 PMID: 10845900 06/14/2000
  • T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. (Champlin RE, Passweg JR, Zhang MJ, Rowlings PA, Pelz CJ, Atkinson KA, Barrett AJ, Cahn JY, Drobyski WR, Gale RP, Goldman JM, Gratwohl A, Gordon-Smith EC, Henslee-Downey PJ, Herzig RH, Klein JP, Marmont AM, O'Reilly RJ, Ringdén O, Slavin S, Sobocinski KA, Speck B, Weiner RS, Horowitz MM) Blood 2000 Jun 15;95(12):3996-4003 PMID: 10845940 06/14/2000
  • Current status of allogeneic bone marrow transplantation in acquired aplastic anemia. (Horowitz MM) Semin Hematol 2000 Jan;37(1):30-42 PMID: 10676909 02/17/2000
  • New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. (Socié G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB, Sullivan KM, Rowlings PA, Kingma DW, Banks PM, Travis WD, Witherspoon RP, Sanders J, Jaffe ES, Horowitz MM) J Clin Oncol 2000 Jan;18(2):348-57 PMID: 10637249 01/19/2000
  • Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. (Davies SM, Ramsay NK, Klein JP, Weisdorf DJ, Bolwell B, Cahn JY, Camitta BM, Gale RP, Giralt S, Heilmann C, Henslee-Downey PJ, Herzig RH, Hutchinson R, Keating A, Lazarus HM, Milone GA, Neudorf S, Perez WS, Powles RL, Prentice HG, Schiller G, Socié G, Vowels M, Wiley J, Yeager A, Horowitz MM) J Clin Oncol 2000 Jan;18(2):340-7 PMID: 10637248 01/19/2000
  • Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry. (Giralt S, Szydlo R, Goldman JM, Veum-Stone J, Biggs JC, Herzig RH, Klein JP, McGlave PB, Schiller G, Gale RP, Rowlings PA, Horowitz MM) Blood 2000 Jan 15;95(2):410-5 PMID: 10627443 01/11/2000
  • Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. (Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, Pelz CJ, Klein JP, Sobocinski KA, Kennedy MJ, Freytes CO, McCarthy PL Jr, Herzig RH, Stadtmauer EA, Lazarus HM, Pecora AL, Bitran JD, Wolff SN, Gale RP, Armitage JO, Vaughan WP, Spitzer G, Horowitz MM) JAMA 1999 Oct 13;282(14):1335-43 PMID: 10527180 10/20/1999
  • Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. (Rowlings PA, Curtis RE, Passweg JR, Deeg HJ, Socié G, Travis LB, Kingma DW, Jaffe ES, Sobocinski KA, Horowitz MM) J Clin Oncol 1999 Oct;17(10):3122-7 PMID: 10506608 10/03/1999
  • Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. (Curtis RE, Travis LB, Rowlings PA, Socié G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF Jr, Deeg HJ) Blood 1999 Oct 01;94(7):2208-16 PMID: 10498590 09/25/1999
  • Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase. (Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR) Leuk Res 1999 Sep;23(9):817-26 PMID: 10475621 09/04/1999
  • Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry. (McCarthy P, Hurd D, Rowlings P, Crump M, Gale R, Lazarus H, Vaughan W, Weinberger B, Wiemann M, Freytes C, Cirenza E, Antman K) Bone Marrow Transplant 1999 Aug;24(4):365-8 PMID: 10467324 09/01/1999
  • Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission. (Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR) Leuk Res 1999 Aug;23(8):709-18 PMID: 10456668 08/24/1999
  • Modelling covariate adjusted mortality relative to a standard population. (Andersen PK, Horowitz MM, Klein JP, Socie G, Stone JV, Zhang MJ) Stat Med 1999 Jun 30;18(12):1529-40 PMID: 10398290 07/09/1999
  • Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. (Horowitz MM, Przepiorka D, Bartels P, Buell DN, Zhang MJ, Fitzsimmons WE, Erdman J, Huang C, Hodosh E, Maher R, Wingard JR) Biol Blood Marrow Transplant 1999;5(3):180-6 PMID: 10392964 07/07/1999
  • Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. (Lazarus HM, Rowlings PA, Zhang MJ, Vose JM, Armitage JO, Bierman PJ, Gajewski JL, Gale RP, Keating A, Klein JP, Miller CB, Phillips GL, Reece DE, Sobocinski KA, van Besien K, Horowitz MM) J Clin Oncol 1999 Feb;17(2):534-45 PMID: 10080597 03/18/1999
  • Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. (Saso R, Marsh J, Cevreska L, Szer J, Gale RP, Rowlings PA, Passweg JR, Nugent ML, Luzzatto L, Horowitz MM, Gordon-Smith EC) Br J Haematol 1999 Feb;104(2):392-6 PMID: 10050724 03/02/1999
  • Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. (Hale G, Zhang MJ, Bunjes D, Prentice HG, Spence D, Horowitz MM, Barrett AJ, Waldmann H) Blood 1998 Dec 15;92(12):4581-90 PMID: 9845524 12/09/1998
  • Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission. (Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR) Leuk Res 1998 Nov;22(11):973-81 PMID: 9783798 10/23/1998
  • Initial therapy for chronic myelogenous leukemia: playing the odds. (Lee SJ, Anasetti C, Horowitz MM, Antin JH) J Clin Oncol 1998 Sep;16(9):2897-903 PMID: 9738555 09/17/1998
  • Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission. (Oh H, Gale RP, Zhang MJ, Passweg JR, Ino T, Murakami H, Ohno R, Rowlings PA, Sobocinski KA, Tanimoto M, Tomonaga M, Weisdorf DJ, Horowitz MM) Bone Marrow Transplant 1998 Aug;22(3):253-7 PMID: 9720738 08/28/1998
  • Allogeneic bone marrow transplantation for low-grade lymphoma. (van Besien K, Sobocinski KA, Rowlings PA, Murphy SC, Armitage JO, Bishop MR, Chaekal OK, Gale RP, Klein JP, Lazarus HM, McCarthy PL Jr, Raemaekers JM, Reiffers J, Phillips GL, Schattenberg AV, Verdonck LF, Vose JM, Horowitz MM) Blood 1998 Sep 01;92(5):1832-6 PMID: 9716615 08/26/1998
  • Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. (Passweg JR, Rowlings PA, Atkinson KA, Barrett AJ, Gale RP, Gratwohl A, Jacobsen N, Klein JP, Ljungman P, Russell JA, Schaefer UW, Sobocinski KA, Vossen JM, Zhang MJ, Horowitz MM) Bone Marrow Transplant 1998 Jun;21(12):1231-8 PMID: 9674857 07/23/1998
  • Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. (Sullivan KM, Anasetti C, Horowitz M, Rowlings PA, Petersdorf EW, Martin PJ, Clift RA, Walters MC, Gooley T, Sierra J, Anderson JE, Bjerke J, Siadak M, Flowers ME, Nash RA, Sanders JE, Appelbaum FR, Storb R, Hansen JA) Ann N Y Acad Sci 1998 Jun 30;850:312-24 PMID: 9668553 07/21/1998
  • Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know? (Waters TM, Bennett CL, Pajeau TS, Sobocinski KA, Klein JP, Rowlings PA, Horowitz MM) Bone Marrow Transplant 1998 Apr;21(7):641-50 PMID: 9578302 05/13/1998
  • Related donor bone marrow transplantation for chronic myelogenous leukemia. (Passweg JR, Rowlings PA, Horowitz MM) Hematol Oncol Clin North Am 1998 Feb;12(1):81-92 PMID: 9523226 04/02/1998
  • Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation. (Chen CS, Seidel K, Armitage JO, Fay JW, Appelbaum FR, Horowitz MM, Shpall EJ, Weiden PL, Antman KS, Champlin RE, Kersey JH, Sullivan KM) Biol Blood Marrow Transplant 1997 Dec;3(6):331-40 PMID: 9502301 03/21/1998
  • Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group. (Gale RP, Hehlmann R, Zhang MJ, Hasford J, Goldman JM, Heimpel H, Hochhaus A, Klein JP, Kolb HJ, McGlave PB, Passweg JR, Rowlings PA, Sobocinski KA, Horowitz MM) Blood 1998 Mar 01;91(5):1810-9 PMID: 9473250 03/21/1998
  • Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. (Passweg JR, Tiberghien P, Cahn JY, Vowels MR, Camitta BM, Gale RP, Herzig RH, Hoelzer D, Horowitz MM, Ifrah N, Klein JP, Marks DI, Ramsay NK, Rowlings PA, Weisdorf DJ, Zhang MJ, Barrett AJ) Bone Marrow Transplant 1998 Jan;21(2):153-8 PMID: 9489632 03/07/1998
  • Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. (Lawton CA, Cohen EP, Murray KJ, Derus SW, Casper JT, Drobyski WR, Horowitz MM, Moulder JE) Bone Marrow Transplant 1997 Dec;20(12):1069-74 PMID: 9466280 02/18/1998
  • Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis. (Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH) Ann Intern Med 1997 Dec 15;127(12):1080-8 PMID: 9412310 12/31/1997
  • An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation. (Horowitz MM, Rowlings PA) Curr Opin Hematol 1997 Nov;4(6):395-400 PMID: 9358995 11/14/1997
  • Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy. (Zhang MJ, Baccarani M, Gale RP, McGlave PB, Atkinson K, Champlin RE, Dicke KA, Giralt S, Gluckman E, Goldman JM, Klein JP, Herzig RH, Masaoka T, O'Reilly RJ, Rozman C, Rowlings PA, Sobocinski KA, Speck B, Zwaan FE, Horowitz MM) Br J Haematol 1997 Oct;99(1):23-9 PMID: 9359497 11/14/1997
  • Bone marrow transplantation for severe aplastic anemia: has outcome improved? (Passweg JR, Socié G, Hinterberger W, Bacigalupo A, Biggs JC, Camitta BM, Champlin RE, Gale RP, Gluckman E, Gordon-Smith EC, Hows JM, Klein JP, Nugent ML, Pasquini R, Rowlings PA, Speck B, Tichelli A, Zhang MJ, Horowitz MM, Bortin MM) Blood 1997 Jul 15;90(2):858-64 PMID: 9226187 07/15/1997
  • IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. (Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, Cahn JY, Calderwood S, Gratwohl A, Socié G, Abecasis MM, Sobocinski KA, Zhang MJ, Horowitz MM) Br J Haematol 1997 Jun;97(4):855-64 PMID: 9217189 06/01/1997
  • High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. (Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy PL Jr, Saez R, Spitzer G, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM) J Clin Oncol 1997 May;15(5):1870-9 PMID: 9164197 05/01/1997
  • Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. (Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL, Gluckman E, Henslee-Downey PJ, Hows JM, Jacobsen N, Kolb HJ, Lowenberg B, Masaoka T, Rowlings PA, Sondel PM, van Bekkum DW, van Rood JJ, Vowels MR, Zhang MJ, Horowitz MM) J Clin Oncol 1997 May;15(5):1767-77 PMID: 9164184 05/01/1997
  • Solid cancers after bone marrow transplantation. (Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socíe G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr) N Engl J Med 1997 Mar 27;336(13):897-904 PMID: 9070469 03/27/1997
  • Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. (Hinterberger W, Rowlings PA, Hinterberger-Fischer M, Gibson J, Jacobsen N, Klein JP, Kolb HJ, Stevens DA, Horowitz MM, Gale RP) Ann Intern Med 1997 Jan 15;126(2):116-22 PMID: 9005745 01/15/1997
  • HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission. (Gale RP, Büchner T, Zhang MJ, Heinecke A, Champlin RE, Dicke KA, Gluckman E, Good RA, Gratwohl A, Herzig RH, Keating A, Klein JP, Marmont AM, Prentice HG, Rowlings PA, Sobocinski KA, Speck B, Weiner RS, Horowitz MM) Leukemia 1996 Nov;10(11):1687-91 PMID: 8892667 11/01/1996
  • Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry. (Horowitz MM, Rowlings PA, Passweg JR) Bone Marrow Transplant 1996 May;17 Suppl 3:S5-6 PMID: 8769690 05/01/1996
  • Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. (Gajewski JL, Phillips GL, Sobocinski KA, Armitage JO, Gale RP, Champlin RE, Herzig RH, Hurd DD, Jagannath S, Klein JP, Lazarus HM, McCarthy PL Jr, Pavlovsky S, Peterson FB, Rowlings PA, Russell JA, Silver SM, Vose JM, Wiernik PH, Bortin MM, Horowitz MM) J Clin Oncol 1996 Feb;14(2):572-8 PMID: 8636773 02/01/1996
  • Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. (Rozman C, Carreras E, Qian C, Gale RP, Bortin MM, Rowlings PA, Ash RC, Champlin RE, Henslee-Downey PJ, Herzig RH, Hinterberger W, Klein JP, Prentice HG, Reiffers J, Zwaan FE, Horowitz MM) Bone Marrow Transplant 1996 Jan;17(1):75-80 PMID: 8673059 01/01/1996
  • Chemotherapy versus transplants for acute myelogenous leukemia in second remission. (Gale RP, Horowitz MM, Rees JK, Gray RG, Oken MM, Estey EH, Kim KM, Zhang MJ, Ash RC, Atkinson K, Champlin RE, Dicke KA, Gajewski JL, Goldman JM, Helbig W, Henslee-Downey PS, Hinterberger W, Jacobsen N, Keating A, Klein JP, Marmont AM, Prentice HG, Reiffers J, Rimm AA, Bortin MM) Leukemia 1996 Jan;10(1):13-9 PMID: 8558917 01/01/1996
  • Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia. (Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR) Blood 1995 Nov 15;86(10):3987-96 PMID: 7579370 11/15/1995
  • Bone marrow transplantation for Fanconi anemia. (Gluckman E, Auerbach AD, Horowitz MM, Sobocinski KA, Ash RC, Bortin MM, Butturini A, Camitta BM, Champlin RE, Friedrich W, Good RA, Gordon-Smith EC, Harris RE, Klein JP, Ortega JJ, Pasquini R, Ramsay NK, Speck B, Vowels MR, Zhang MJ, Gale RP) Blood 1995 Oct 01;86(7):2856-62 PMID: 7670120 10/01/1995
  • Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee. (Zhang MJ, Hoelzer D, Horowitz MM, Gale RP, Messerer D, Klein JP, Löffler H, Sobocinski KA, Thiel E, Weisdorf DJ) Ann Intern Med 1995 Sep 15;123(6):428-31 PMID: 7639442 09/15/1995
  • Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. (Gale RP, Horowitz MM, Weiner RS, Ash RC, Atkinson K, Babu R, Dicke KA, Klein JP, Lowenberg B, Reiffers J) Bone Marrow Transplant 1995 Aug;16(2):203-8 PMID: 7581137 08/01/1995
  • Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. (Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, Drobyski WR, Ash RC, Horowitz MM, Camitta B, Lawton C) Bone Marrow Transplant 1995 Aug;16(2):271-5 PMID: 7581147 08/01/1995
  • Allogeneic marrow grafts from donors with congenital chromosomal abnormalities in marrow cells. (Barquinero J, Witherspoon R, Sanders J, Horowitz MM, Montuoro A, Patton DF, Bacigalupo A, Abecasis MM, Miale T, Rozman C) Br J Haematol 1995 Jul;90(3):595-601 PMID: 7646999 07/01/1995
  • Bone-marrow transplantation for leukaemia. (Gale RP, Goldman JM, Horowitz MM, Silberman G, Crosse MG, Peterson EA, Weston RC) Lancet 1995 May 13;345(8959):1235 PMID: 7739318 05/13/1995
  • Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America. (Passweg JR, Rowlings PA, Armitage JO, Gale RP, Pelz CJ, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM) Clin Transpl 1995:117-27 PMID: 8794259 01/01/1995
  • Bone marrow transplantation for Diamond-Blackfan anemia. (Mugishima H, Gale RP, Rowlings PA, Horowitz MM, Marmont AM, McCann SR, Sobocinski KA, Bortin MM) Bone Marrow Transplant 1995 Jan;15(1):55-8 PMID: 7742755 01/01/1995
  • Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. (Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA) N Engl J Med 1994 Nov 10;331(19):1253-8 PMID: 7935682 11/10/1994
  • Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. (Silberman G, Crosse MG, Peterson EA, Weston RC, Horowitz MM, Appelbaum FR, Cheson BD) N Engl J Med 1994 Oct 20;331(16):1063-7 PMID: 8090167 10/20/1994
  • Comparison of chemotherapy and bone marrow transplants using two independent clinical databases. (Messerer D, Neiss A, Horowitz MM, Hoelzer D, Gale RP) J Clin Epidemiol 1994 Oct;47(10):1119-26 PMID: 7722545 10/01/1994
  • Identical-twin bone marrow transplants for leukemia. (Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA, Ringdén O, Stone JA, Bortin MM) Ann Intern Med 1994 Apr 15;120(8):646-52 PMID: 8135448 04/15/1994
  • Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. (Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F) Blood 1994 Apr 01;83(7):1980-7 PMID: 8142664 04/01/1994
  • Increasing incidence of adenovirus disease in bone marrow transplant recipients. (Flomenberg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV, McAuliffe T, Camitta B, Horowitz MM, Bunin N) J Infect Dis 1994 Apr;169(4):775-81 PMID: 8133091 04/01/1994
  • Bone marrow transplantation in leukemia. (Rowlings PA, Gale RP, Horowitz MM, Bortin MM) J Hematother 1994;3(3):235-8 PMID: 7827872 01/01/1994
  • Bone marrow transplantation--1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. (Sobocinski KA, Horowitz MM, Rowlings PA, Zhang MJ, Nugent ML, Passweg JR, Armitage JO, Gale RP, Bortin MM) J Hematother 1994;3(2):95-102 PMID: 7922018 01/01/1994
  • Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America. (Rowlings PA, Passweg JR, Armitage JO, Gale RP, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM) Clin Transpl 1994:87-98 PMID: 7547596 01/01/1994
  • Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. (Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, Gottschall JL, Ash RC, van Tuinen P, Horowitz MM) Blood 1993 Oct 15;82(8):2310-8 PMID: 8400284 10/15/1993
  • Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. (Goldman JM, Szydlo R, Horowitz MM, Gale RP, Ash RC, Atkinson K, Dicke KA, Gluckman E, Herzig RH, Marmont A) Blood 1993 Oct 01;82(7):2235-8 PMID: 8400272 10/01/1993
  • 1993 progress report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry. (Bortin MM, Horowitz MM, Rowlings PA, Rimm AA, Sobocinski KA, Zhang MJ, Gale RP) Bone Marrow Transplant 1993 Aug;12(2):97-104 PMID: 8401371 08/01/1993
  • Outcome after allogeneic bone marrow transplant for leukemia in older adults. (Ringdén O, Horowitz MM, Gale RP, Biggs JC, Gajewski J, Rimm AA, Speck B, Veum-Stone JA, de Witte T, Bortin MM) JAMA 1993 Jul 07;270(1):57-60 PMID: 8510297 07/07/1993
  • The role of the International Bone Marrow Transplant Registry in assessing clinical efficacy. (Horowitz MM) Leukemia 1993 Jul;7(7):1106 PMID: 8321036 07/01/1993
  • Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. (Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM, Flomenberg N, Carrigan DR) J Infect Dis 1993 Mar;167(3):735-9 PMID: 8382723 03/01/1993
  • Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? (Ringdén O, Horowitz MM, Sondel P, Gale RP, Biggs JC, Champlin RE, Deeg HJ, Dicke K, Masaoka T, Powles RL) Blood 1993 Feb 15;81(4):1094-101 PMID: 8427991 02/15/1993
  • Results of bone marrow transplants from human leukocyte antigen-identical sibling donors for treatment of childhood leukemias. A report from the International Bone Marrow Transplant Registry. (Horowitz MM, Bortin MM) Am J Pediatr Hematol Oncol 1993 Feb;15(1):56-64 PMID: 8383476 02/01/1993
  • Alternative donor transplants for leukemia. Scientific Advisory Committee of the International Bone Marrow Transplant Registry. (Gale RP, Horowitz MM) Bone Marrow Transplant 1993;11 Suppl 1:66-7 PMID: 8448552 01/01/1993
  • Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. (Rowlings PA, Horowitz MM, Armitage JO, Gale RP, Sobocinski KA, Zhang MJ, Bortin MM) Clin Transpl 1993:101-8 PMID: 7918143 01/01/1993
  • Anti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors. (Krance R, Heslop HE, Mahmoud H, Ribeiro R, Douglass E, Hurwitz C, Santana V, Kun L, Horowitz MM, Brenner MK) Bone Marrow Transplant 1993 Jan;11(1):33-6 PMID: 8431709 01/01/1993
  • Predicting results of alternative donor transplants for thalassemia using a chronic myelogenous leukemia model. (Gale RP, Horowitz MM) Bone Marrow Transplant 1993;12 Suppl 1:82-3 PMID: 8374572 01/01/1993
  • Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. (Biggs JC, Horowitz MM, Gale RP, Ash RC, Atkinson K, Helbig W, Jacobsen N, Phillips GL, Rimm AA, Ringdén O) Blood 1992 Aug 15;80(4):1090-3 PMID: 1498326 08/15/1992
  • Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s. (Bortin MM, Horowitz MM, Gale RP, Barrett AJ, Champlin RE, Dicke KA, Gluckman E, Kolb HJ, Marmont AM, Mrsic M) JAMA 1992 Aug 05;268(5):607-12 PMID: 1321298 08/05/1992
  • Progress report from the International Bone Marrow Transplant Registry. (Bortin MM, Horowitz MM, Rimm AA) Bone Marrow Transplant 1992 Aug;10(2):113-22 PMID: 1525599 08/01/1992
  • What determines who develops graft-versus-host disease: the graft or the host (or both)? (Gale RP, Horowitz MM, Butturini A, Barrett AJ, Kolb HJ) Bone Marrow Transplant 1992 Aug;10(2):99-102 PMID: 1525613 08/01/1992
  • Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. (Barrett AJ, Horowitz MM, Ash RC, Atkinson K, Gale RP, Goldman JM, Henslee-Downey PJ, Herzig RH, Speck B, Zwaan FE) Blood 1992 Jun 01;79(11):3067-70 PMID: 1586748 06/01/1992
  • Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? (Horowitz MM, Przepiorka D, Champlin RE, Gale RP, Gratwohl A, Herzig RH, Prentice HG, Rimm AA, Ringdén O, Bortin MM) Blood 1992 May 15;79(10):2771-4 PMID: 1586723 05/15/1992
  • Second HLA-identical sibling transplants for leukemia recurrence. (Mrsíc M, Horowitz MM, Atkinson K, Biggs JC, Champlin RE, Ehninger G, Gajewski JL, Gale RP, Herzig RH, Prentice HG) Bone Marrow Transplant 1992 Apr;9(4):269-75 PMID: 1600415 04/01/1992
  • Increasing utilization of allogeneic bone marrow transplantation. Results of the 1988-1990 survey. (Bortin MM, Horowitz MM, Rimm AA) Ann Intern Med 1992 Mar 15;116(6):505-12 PMID: 1739242 03/15/1992
  • Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. (Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs JC, Camitta BM, Gale RP, Gordon-Smith EC, Marmont AM) Blood 1992 Jan 01;79(1):269-75 PMID: 1728315 01/01/1992
  • Progress in allogeneic bone marrow transplantation for acute lymphoblastic leukemia in the 1980's: a report from the IBMTR. The International Bone Marrow Transplant Registry. (Bortin MM, Barrett AJ, Horowitz MM, Gale RP, Sobocinski KA, Rimm AA) Leukemia 1992;6 Suppl 2:196-7 PMID: 1578932 01/01/1992
  • Report from the International Bone Marrow Transplant Registry. (Rowlings PA, Horowitz MM, Rimm AA, Sobocinski KA, Zhang MJ, Bortin MM) Clin Transpl 1992:83-90 PMID: 1306725 01/01/1992
  • Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects. (Kolb HJ, Guenther W, Duell T, Socie G, Schaeffer E, Holler E, Schumm M, Horowitz MM, Gale RP, Fliedner TM) Bone Marrow Transplant 1992;10 Suppl 1:135-8 PMID: 1521085 01/01/1992
  • Therapy decisions in leukemia. (Atkinson KA, Horowitz MM, Sobocinski KA, Rimm AA, Bortin MM, Gale RP) Bone Marrow Transplant 1992 Jan;9(1):5-10 PMID: 1543950 01/01/1992
  • Current status of allogeneic bone marrow transplantation. (Sobocinski KA, Horowitz MM, Rimm AA, Bortin MM) Biomed Pharmacother 1992;46(2-3):57-69 PMID: 1421039 01/01/1992
  • Transplants in ALL. (Barrett AJ, Horowitz MM) Bone Marrow Transplant 1992;10 Suppl 1:30-6 PMID: 1521088 01/01/1992
  • T-cell depletion of HLA-identical transplants in leukemia. (Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA) Blood 1991 Oct 15;78(8):2120-30 PMID: 1912589 10/15/1991
  • Evaluating new therapy for acute myeloid leukemia. (Keating A, Horowitz MM) Semin Hematol 1991 Jul;28(3 Suppl 4):70-1 PMID: 1780755 07/01/1991
  • Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. (Horowitz MM, Messerer D, Hoelzer D, Gale RP, Neiss A, Atkinson K, Barrett AJ, Büchner T, Freund M, Heil G) Ann Intern Med 1991 Jul 01;115(1):13-8 PMID: 2048858 07/01/1991
  • Does more intensive therapy increase cures in acute leukemia? (Gale RP, Butturini A, Horowitz MM) Semin Hematol 1991 Jul;28(3 Suppl 4):93-4 PMID: 1780762 07/01/1991
  • Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. (Ash RC, Horowitz MM, Gale RP, van Bekkum DW, Casper JT, Gordon-Smith EC, Henslee PJ, Kolb HJ, Lowenberg B, Masaoka T) Bone Marrow Transplant 1991 Jun;7(6):443-52 PMID: 1873591 06/01/1991
  • Autotransplants in acute leukaemia. (Gale RP, Horowitz MM, Butturini A) Br J Haematol 1991 May;78(1):135-7 PMID: 2043473 05/01/1991
  • Duration of response to intramuscular versus low dose intradermal hepatitis B booster immunization. (McKinney WP, Russler SK, Horowitz MM, Battiola RJ, Lee MB) Infect Control Hosp Epidemiol 1991 Apr;12(4):226-30 PMID: 1829469 04/01/1991
  • Progress in bone marrow transplantation for leukemia: a preliminary report from the Advisory Committee of the International Bone Marrow Transplant Registry. (Bortin MM, Horowitz MM, Mrsic M, Rimm AA, Sobocinski KA) Transplant Proc 1991 Feb;23(1 Pt 1):61-2 PMID: 1990623 02/01/1991
  • Use of a clinical data registry to evaluate medical technologies. Experience from the International Bone Marrow Transplant Registry. (Rimm AA, Barr JT, Horowitz MM, Bortin MM) Int J Technol Assess Health Care 1991;7(2):182-93 PMID: 1864702 01/01/1991
  • How best to analyse new strategies in bone marrow transplantation. (Gale RP, Horowitz MM) Bone Marrow Transplant 1990 Dec;6(6):357-9 PMID: 2097005 12/01/1990
  • Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry. (Gale RP, Horowitz MM) Bone Marrow Transplant 1990 Jul;6 Suppl 1:94-7 PMID: 2390646 07/01/1990
  • Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. (Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA, Jacobsen N, Kolb HJ, Rimm AA, Ringdén O) Blood 1990 Jun 15;75(12):2459-64 PMID: 2350582 06/15/1990
  • Graft-versus-leukemia reactions after bone marrow transplantation. (Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringdén O, Rozman C, Speck B) Blood 1990 Feb 01;75(3):555-62 PMID: 2297567 02/01/1990
  • Current status of allogeneic bone marrow transplantation. (Horowitz MM, Bortin MM) Clin Transpl 1990:41-52 PMID: 2103163 01/01/1990
  • IBMTR analysis of bone marrow transplants in acute leukaemia. Advisory Committee of the International Bone Marrow Transplant Registry (IBMTR). (Gale RP, Horowitz MM, Bortin MM) Bone Marrow Transplant 1989 Dec;4 Suppl 3:83-4 PMID: 2697411 12/01/1989
  • Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. (Barrett AJ, Horowitz MM, Gale RP, Biggs JC, Camitta BM, Dicke KA, Gluckman E, Good RA, Herzig RH, Lee MB) Blood 1989 Aug 01;74(2):862-71 PMID: 2665858 08/01/1989
  • Temporal relationships between the major complications of bone marrow transplantation for leukemia. (Bortin MM, Ringdén O, Horowitz MM, Rozman C, Weiner RS, Rimm AA) Bone Marrow Transplant 1989 Jul;4(4):339-44 PMID: 2673453 07/01/1989
  • Proposals for standardized reporting of results of bone marrow transplantation for leukaemia. (Clift R, Goldman J, Gratwohl A, Horowitz M) Bone Marrow Transplant 1989 Jul;4(4):445-8 PMID: 2673466 07/01/1989
  • Transplant or chemotherapy in acute myelogenous leukaemia. International Bone Marrow Transplant Registry. Lancet 1989 May 20;1(8647):1119-22 PMID: 2566059 05/20/1989
  • Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry. (Atkinson K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM) Bone Marrow Transplant 1989 May;4(3):247-54 PMID: 2659110 05/01/1989
  • Risk factors for interstitial pneumonia following bone marrow transplantation for severe aplastic anaemia. (Weiner RS, Horowitz MM, Gale RP, Dicke KA, van Bekkum DW, Masaoka T, Ramsay NK, Rimm AA, Rozman C, Bortin MM) Br J Haematol 1989 Apr;71(4):535-43 PMID: 2653409 04/01/1989
  • Effect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukaemia. International Bone Marrow Transplant Registry. Lancet 1989 Mar 11;1(8637):535-7 PMID: 2564066 03/11/1989
  • Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. (Champlin RE, Horowitz MM, van Bekkum DW, Camitta BM, Elfenbein GE, Gale RP, Gluckman E, Good RA, Rimm AA, Rozman C) Blood 1989 Feb;73(2):606-13 PMID: 2644980 02/01/1989
  • Graft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry. (Ringdén O, Horowitz MM) Transplant Proc 1989 Feb;21(1 Pt 3):2989-92 PMID: 2650409 02/01/1989
  • Susceptibility of hospital-based health care personnel to varicella-zoster virus infections. (McKinney WP, Horowitz MM, Battiola RJ) Am J Infect Control 1989 Feb;17(1):26-30 PMID: 2538095 02/01/1989
  • Current status of bone marrow transplantation. (Bortin MM, Horowitz MM) Clin Transpl 1989:93-104 PMID: 2487630 01/01/1989
  • Factors influencing the risk of acute and chronic graft-versus-host disease in humans: a preliminary report from the IBMTR. (Bortin MM, Atkinson K, van Bekkum DW, Biggs JC, Dicke KA, Gale RP, Gluckman E, Good RA, Hoffmann RG, Horowitz MM) Bone Marrow Transplant 1989 Jan;4 Suppl 1:222-4 PMID: 2653507 01/01/1989
  • Bone marrow transplantation for acute lymphoblastic leukaemia in first and second remission. (Barrett AJ, Horowitz MM, McCarthy DM, Kanfer E, Bortin MM) Bone Marrow Transplant 1989 Jan;4 Suppl 1:247-9 PMID: 2653514 01/01/1989
  • Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. (Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E, Hoffmann RG, Jacobsen SJ, Marmont AM, McGlave PB) Ann Intern Med 1988 Jun;108(6):806-14 PMID: 3285744 06/01/1988
  • Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine. (Horowitz MM, Ershler WB, McKinney WP, Battiola RJ) Ann Intern Med 1988 Feb;108(2):185-9 PMID: 2963570 02/01/1988
  • The clinical diagnosis of acute graft-versus-host disease: a diversity of views amongst marrow transplant centers. (Atkinson K, Horowitz MM, Biggs JC, Gale RP, Rimm AA, Bortin MM) Bone Marrow Transplant 1988 Jan;3(1):5-10 PMID: 3048470 01/01/1988
  • Current status of bone marrow transplantation in humans: report from the International Bone Marrow Transplant Registry. (Bortin MM, Horowitz MM, Gale RP) Nat Immun Cell Growth Regul 1988;7(5-6):334-50 PMID: 3065641 01/01/1988
  • Attitudes of faculty members, residents, students, and community physicians toward health promotion. (Horowitz MM, Byrd JC, Gruchow HW) J Med Educ 1987 Nov;62(11):931-4 PMID: 3681923 11/01/1987
  • Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remission. (Herzig RH, Bortin MM, Barrett AJ, Blume KG, Gluckman E, Horowitz MM, Jacobsen SJ, Marmont A, Masaoka T, Prentice HG) Lancet 1987 Apr 04;1(8536):786-9 PMID: 2882192 04/04/1987
  • [Kinin-inactivating enzymes from plants. 1. Partial purification of bradykinin-inactivating enzyme from potatoes]. (Hojima Y, Tanaka M, Moriya H, Moriwaki C) Arerugi 1971 Oct;20(10):755-62 PMID: 5145732 10/01/1971
  • Last update: 06/19/2017
    jenkins-FCD Prod-106 bf6a561a509ceb2e2c031c53c40b81b12394cec4